Gene Symbol | Gene ID | Gene Info |
---|---|---|
Lhx4
|
ENSMUSG00000026468.8 | LIM homeobox protein 4 |
CRE | Gene | Distance | Association probability | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|---|---|
chr1_155741976_155742391 | Lhx4 | 156 | 0.943685 | 0.73 | 2.9e-10 | Click! |
chr1_155742423_155742619 | Lhx4 | 494 | 0.754902 | 0.71 | 9.9e-10 | Click! |
chr1_155750652_155750824 | Lhx4 | 946 | 0.488744 | 0.47 | 2.6e-04 | Click! |
Move your cursor over a bar to see sample name and corresponding Z-value.
Cis Regulatory Element (CRE) | Target Score | Top associated gene | Gene Info | Distance of CRE to TSS | CRE/Gene association probability |
---|---|---|---|---|---|
chr17_66869624_66870037 | 31.24 |
Gm49940 |
predicted gene, 49940 |
7590 |
0.18 |
chr3_17789514_17789745 | 24.55 |
Mir124-2hg |
Mir124-2 host gene (non-protein coding) |
292 |
0.9 |
chrX_166344291_166344543 | 24.25 |
Gpm6b |
glycoprotein m6b |
275 |
0.93 |
chr16_63747767_63748162 | 22.48 |
Gm22769 |
predicted gene, 22769 |
430 |
0.91 |
chr9_122635277_122635496 | 22.46 |
Gm47134 |
predicted gene, 47134 |
12444 |
0.13 |
chr2_53437450_53438022 | 21.89 |
Gm13501 |
predicted gene 13501 |
39249 |
0.2 |
chr19_41164805_41164972 | 21.21 |
Tll2 |
tolloid-like 2 |
41886 |
0.16 |
chr18_45014470_45014883 | 20.37 |
Gm31706 |
predicted gene, 31706 |
30186 |
0.16 |
chr9_9263661_9263812 | 20.07 |
Gm16833 |
predicted gene, 16833 |
3053 |
0.29 |
chr8_31895464_31895660 | 19.99 |
Nrg1 |
neuregulin 1 |
8976 |
0.25 |
chr1_96346717_96347057 | 19.93 |
Gm37076 |
predicted gene, 37076 |
33645 |
0.18 |
chr13_83749857_83750036 | 19.83 |
C130071C03Rik |
RIKEN cDNA C130071C03 gene |
11083 |
0.12 |
chr5_20056465_20056826 | 19.64 |
Gm23570 |
predicted gene, 23570 |
35970 |
0.2 |
chr9_101472906_101473083 | 18.96 |
Gm5161 |
predicted pseudogene 5161 |
23641 |
0.18 |
chr2_34106829_34107151 | 18.67 |
C230014O12Rik |
RIKEN cDNA C230014O12 gene |
739 |
0.69 |
chr10_84710909_84711119 | 18.16 |
Rfx4 |
regulatory factor X, 4 (influences HLA class II expression) |
45048 |
0.13 |
chr3_120982893_120983085 | 17.88 |
Gm43444 |
predicted gene 43444 |
37787 |
0.16 |
chr2_106512677_106513062 | 17.73 |
Gm14015 |
predicted gene 14015 |
10234 |
0.26 |
chr3_79475048_79475264 | 17.20 |
Fnip2 |
folliculin interacting protein 2 |
8951 |
0.21 |
chr4_21095762_21096024 | 17.03 |
Gm11871 |
predicted gene 11871 |
84953 |
0.1 |
chr3_78792451_78792970 | 16.87 |
Gm18952 |
predicted gene, 18952 |
34091 |
0.19 |
chr6_61042953_61043250 | 16.71 |
Gm43892 |
predicted gene, 43892 |
1892 |
0.33 |
chr3_16819794_16819956 | 16.68 |
Gm26485 |
predicted gene, 26485 |
3437 |
0.4 |
chr9_66933818_66934187 | 16.14 |
Rps27l |
ribosomal protein S27-like |
12084 |
0.15 |
chr2_132427639_132427949 | 15.92 |
4921508D12Rik |
RIKEN cDNA 4921508D12 gene |
3053 |
0.25 |
chr8_103314388_103314575 | 15.57 |
1600027J07Rik |
RIKEN cDNA 1600027J07 gene |
33053 |
0.2 |
chr13_99444397_99444879 | 15.44 |
Map1b |
microtubule-associated protein 1B |
171 |
0.95 |
chr13_99842476_99842627 | 15.42 |
Cartpt |
CART prepropeptide |
58090 |
0.13 |
chr9_37114956_37115270 | 15.23 |
Gm48716 |
predicted gene, 48716 |
3543 |
0.18 |
chr15_36966946_36967298 | 15.01 |
Gm34590 |
predicted gene, 34590 |
28258 |
0.13 |
chr2_41498351_41498548 | 14.98 |
Lrp1b |
low density lipoprotein-related protein 1B |
290629 |
0.01 |
chr15_85463386_85463550 | 14.85 |
7530416G11Rik |
RIKEN cDNA 7530416G11 gene |
39759 |
0.14 |
chr5_4811967_4812118 | 14.60 |
Gm44483 |
predicted gene, 44483 |
9585 |
0.12 |
chr3_3831527_3831694 | 14.58 |
Gm2071 |
predicted gene 2071 |
2326 |
0.38 |
chr6_6603963_6604155 | 14.53 |
Sem1 |
SEM1, 26S proteasome complex subunit |
25396 |
0.18 |
chr13_78580917_78581111 | 14.50 |
Gm48402 |
predicted gene, 48402 |
57003 |
0.14 |
chr2_151631930_151632148 | 14.42 |
Snph |
syntaphilin |
432 |
0.78 |
chr3_18454033_18454237 | 14.41 |
Gm30667 |
predicted gene, 30667 |
7119 |
0.22 |
chr15_95217343_95217494 | 14.38 |
1700129L04Rik |
RIKEN cDNA 1700129L04 gene |
55024 |
0.17 |
chr18_37217169_37217576 | 14.37 |
Gm10544 |
predicted gene 10544 |
38850 |
0.08 |
chr13_26657396_26657590 | 14.35 |
Gm47883 |
predicted gene, 47883 |
23200 |
0.23 |
chr17_71976866_71977017 | 14.18 |
Gm49924 |
predicted gene, 49924 |
49911 |
0.16 |
chr1_70442301_70442703 | 14.13 |
Gm38272 |
predicted gene, 38272 |
129591 |
0.05 |
chr11_26806852_26807151 | 14.09 |
Gm12070 |
predicted gene 12070 |
20368 |
0.19 |
chr7_73354299_73354479 | 14.07 |
Rgma |
repulsive guidance molecule family member A |
21120 |
0.13 |
chr12_47163286_47163464 | 13.92 |
Gm36971 |
predicted gene, 36971 |
1667 |
0.48 |
chr1_81594178_81594459 | 13.90 |
Gm6198 |
predicted gene 6198 |
36835 |
0.2 |
chr11_111844478_111844667 | 13.87 |
Gm11674 |
predicted gene 11674 |
43696 |
0.2 |
chr18_23036938_23037296 | 13.82 |
Nol4 |
nucleolar protein 4 |
1539 |
0.55 |
chr7_96718538_96719200 | 13.80 |
Tenm4 |
teneurin transmembrane protein 4 |
59065 |
0.11 |
chr7_76789063_76789214 | 13.78 |
Gm45210 |
predicted gene 45210 |
89421 |
0.1 |
chr1_53740102_53740664 | 13.46 |
Stk17b |
serine/threonine kinase 17b (apoptosis-inducing) |
22310 |
0.18 |
chr2_57523169_57523407 | 13.45 |
Gm13531 |
predicted gene 13531 |
97579 |
0.07 |
chr2_28797954_28798122 | 13.38 |
Gm13385 |
predicted gene 13385 |
4469 |
0.16 |
chr6_111293807_111293981 | 13.35 |
Grm7 |
glutamate receptor, metabotropic 7 |
201821 |
0.03 |
chr9_92178774_92178925 | 13.34 |
Plscr5 |
phospholipid scramblase family, member 5 |
14087 |
0.22 |
chr1_47163860_47164031 | 13.33 |
Gm28826 |
predicted gene 28826 |
10484 |
0.28 |
chr2_101979368_101979730 | 13.28 |
Gm13919 |
predicted gene 13919 |
60080 |
0.11 |
chr12_50120116_50120285 | 13.21 |
Gm40418 |
predicted gene, 40418 |
109 |
0.98 |
chr7_76393238_76393750 | 13.18 |
Agbl1 |
ATP/GTP binding protein-like 1 |
17568 |
0.28 |
chr10_43106136_43106524 | 13.17 |
Gm29245 |
predicted gene 29245 |
47886 |
0.11 |
chr4_21687885_21688425 | 13.12 |
Prdm13 |
PR domain containing 13 |
2192 |
0.29 |
chr10_26328033_26328184 | 13.04 |
L3mbtl3 |
L3MBTL3 histone methyl-lysine binding protein |
11834 |
0.17 |
chr2_45356875_45357110 | 13.02 |
Gm13479 |
predicted gene 13479 |
273 |
0.94 |
chr12_51002047_51002408 | 13.01 |
Gm40421 |
predicted gene, 40421 |
2646 |
0.28 |
chr3_34331071_34331263 | 13.00 |
Gm38505 |
predicted gene, 38505 |
20545 |
0.21 |
chr6_54552680_54553127 | 12.99 |
Scrn1 |
secernin 1 |
1543 |
0.37 |
chr2_141955236_141955408 | 12.96 |
Fau-ps1 |
Finkel-Biskis-Reilly murine sarcoma virus (FBR-MuSV) ubiquitously expressed (fox derived), pseudogene 1 |
116533 |
0.07 |
chr8_25392912_25393353 | 12.80 |
Gm39147 |
predicted gene, 39147 |
5888 |
0.16 |
chr2_63970238_63970568 | 12.67 |
Fign |
fidgetin |
127585 |
0.06 |
chr16_41786838_41787032 | 12.65 |
Lsamp |
limbic system-associated membrane protein |
253516 |
0.02 |
chr1_30061154_30061322 | 12.61 |
Gm23771 |
predicted gene, 23771 |
75304 |
0.12 |
chr19_50457584_50457735 | 12.59 |
Sorcs1 |
sortilin-related VPS10 domain containing receptor 1 |
204981 |
0.02 |
chr4_76144419_76144591 | 12.53 |
Ptprd |
protein tyrosine phosphatase, receptor type, D |
10362 |
0.31 |
chr2_34107198_34107369 | 12.50 |
C230014O12Rik |
RIKEN cDNA C230014O12 gene |
446 |
0.84 |
chr4_111686063_111686242 | 12.46 |
Spata6 |
spermatogenesis associated 6 |
33832 |
0.2 |
chr7_39588456_39589360 | 12.46 |
Gm2058 |
predicted gene 2058 |
23 |
0.97 |
chr5_71976810_71977063 | 12.45 |
Gm15617 |
predicted gene 15617 |
56552 |
0.14 |
chr2_79059440_79059602 | 12.29 |
Gm14469 |
predicted gene 14469 |
20787 |
0.2 |
chr8_29544323_29544526 | 12.24 |
Nudc-ps1 |
nuclear distribution gene C homolog (Aspergillus), pseudogene 1 |
257443 |
0.02 |
chr6_12117902_12118084 | 12.23 |
Gm6578 |
predicted gene 6578 |
8410 |
0.23 |
chr15_37787189_37787357 | 12.19 |
Ncald |
neurocalcin delta |
4727 |
0.2 |
chrX_60545622_60545821 | 12.19 |
Gm715 |
predicted gene 715 |
2298 |
0.23 |
chr3_55873681_55873832 | 12.08 |
Gm43376 |
predicted gene 43376 |
16550 |
0.19 |
chr6_112809935_112810331 | 12.08 |
Srgap3 |
SLIT-ROBO Rho GTPase activating protein 3 |
19326 |
0.21 |
chr4_148327377_148327851 | 12.02 |
Gm13206 |
predicted gene 13206 |
20761 |
0.14 |
chr13_83985066_83985623 | 12.01 |
Gm4241 |
predicted gene 4241 |
2647 |
0.28 |
chr14_55052295_55052661 | 11.99 |
Zfhx2os |
zinc finger homeobox 2, opposite strand |
1391 |
0.2 |
chr14_35027814_35027992 | 11.98 |
Mir346 |
microRNA 346 |
133294 |
0.05 |
chr5_9703200_9703375 | 11.96 |
Grm3 |
glutamate receptor, metabotropic 3 |
21883 |
0.21 |
chr2_146833312_146833528 | 11.92 |
Gm14114 |
predicted gene 14114 |
6312 |
0.24 |
chr5_111944379_111944557 | 11.91 |
Gm42488 |
predicted gene 42488 |
233 |
0.96 |
chr8_7440241_7440417 | 11.91 |
Gm26427 |
predicted gene, 26427 |
12001 |
0.26 |
chr2_49815790_49816032 | 11.89 |
Gm13480 |
predicted gene 13480 |
2963 |
0.3 |
chr7_96865260_96865776 | 11.86 |
Gm25712 |
predicted gene, 25712 |
2139 |
0.28 |
chr2_51087621_51088075 | 11.82 |
Rnd3 |
Rho family GTPase 3 |
61246 |
0.13 |
chr13_84783651_84783837 | 11.81 |
Gm26913 |
predicted gene, 26913 |
92803 |
0.09 |
chr1_136142237_136142876 | 11.80 |
Kif21b |
kinesin family member 21B |
11102 |
0.11 |
chr4_70743499_70743669 | 11.71 |
Megf9 |
multiple EGF-like-domains 9 |
208589 |
0.03 |
chr1_47104196_47104347 | 11.71 |
Gm28825 |
predicted gene 28825 |
36483 |
0.19 |
chr10_29143863_29144732 | 11.70 |
Gm9996 |
predicted gene 9996 |
103 |
0.69 |
chr2_15656666_15656817 | 11.70 |
Gm37595 |
predicted gene, 37595 |
125628 |
0.05 |
chr5_107497898_107498054 | 11.65 |
Btbd8 |
BTB (POZ) domain containing 8 |
197 |
0.9 |
chr5_46201957_46202226 | 11.64 |
Gm7931 |
predicted pseudogene 7931 |
212253 |
0.02 |
chr4_54329031_54329272 | 11.51 |
Gm12469 |
predicted gene 12469 |
93275 |
0.09 |
chr14_55029006_55029605 | 11.50 |
Ngdn |
neuroguidin, EIF4E binding protein |
7883 |
0.07 |
chr9_58457758_58457974 | 11.49 |
4930461G14Rik |
RIKEN cDNA 4930461G14 gene |
2744 |
0.26 |
chr2_142648071_142648223 | 11.42 |
Kif16b |
kinesin family member 16B |
616 |
0.81 |
chr4_41727338_41727565 | 11.41 |
Arid3c |
AT rich interactive domain 3C (BRIGHT-like) |
2835 |
0.12 |
chr1_46829988_46830169 | 11.39 |
Slc39a10 |
solute carrier family 39 (zinc transporter), member 10 |
5821 |
0.22 |
chr11_88240584_88240997 | 11.38 |
Gm38534 |
predicted gene, 38534 |
12578 |
0.16 |
chr12_12684520_12684723 | 11.33 |
Gm27952 |
predicted gene, 27952 |
2003 |
0.29 |
chr6_15397521_15397861 | 11.32 |
Gm25470 |
predicted gene, 25470 |
7290 |
0.26 |
chr13_83750227_83750397 | 11.31 |
C130071C03Rik |
RIKEN cDNA C130071C03 gene |
11449 |
0.12 |
chr7_51339973_51340169 | 11.30 |
Gm45002 |
predicted gene 45002 |
54758 |
0.15 |
chr8_36195680_36195857 | 11.28 |
Gm35520 |
predicted gene, 35520 |
7396 |
0.16 |
chr12_50191241_50191439 | 11.27 |
Gm40418 |
predicted gene, 40418 |
71031 |
0.14 |
chr13_90136263_90136515 | 11.26 |
Gm37727 |
predicted gene, 37727 |
20765 |
0.16 |
chr12_33225361_33225571 | 11.22 |
Atxn7l1os1 |
ataxin 7-like 1, opposite strand 1 |
3388 |
0.28 |
chr18_27956389_27956743 | 11.20 |
Gm33674 |
predicted gene, 33674 |
146834 |
0.05 |
chr15_30857737_30857940 | 11.20 |
9630009A06Rik |
RIKEN cDNA 9630009A06 gene |
105040 |
0.07 |
chr10_70458638_70458831 | 11.19 |
Fam13c |
family with sequence similarity 13, member C |
17808 |
0.19 |
chr2_123364591_123364759 | 11.10 |
Gm13988 |
predicted gene 13988 |
90751 |
0.1 |
chr3_79417407_79417581 | 11.09 |
Fnip2 |
folliculin interacting protein 2 |
48711 |
0.13 |
chr6_75253494_75253645 | 11.05 |
Gm6210 |
predicted gene 6210 |
44490 |
0.16 |
chr12_90131976_90132183 | 11.04 |
Gm48700 |
predicted gene, 48700 |
63980 |
0.15 |
chr10_72099225_72099381 | 11.04 |
Gm34609 |
predicted gene, 34609 |
72321 |
0.11 |
chr5_90988282_90988433 | 11.02 |
Epgn |
epithelial mitogen |
39107 |
0.11 |
chr12_50190972_50191191 | 11.01 |
Gm40418 |
predicted gene, 40418 |
70772 |
0.14 |
chr5_4651240_4651409 | 10.98 |
Fzd1 |
frizzled class receptor 1 |
106711 |
0.06 |
chr13_52562127_52562509 | 10.95 |
Syk |
spleen tyrosine kinase |
20855 |
0.22 |
chr19_28333153_28333358 | 10.92 |
Glis3 |
GLIS family zinc finger 3 |
7249 |
0.31 |
chr18_74956688_74957137 | 10.86 |
Lipg |
lipase, endothelial |
4350 |
0.11 |
chr1_61407385_61407544 | 10.82 |
9530026F06Rik |
RIKEN cDNA 9530026F06 gene |
29032 |
0.14 |
chr16_79449717_79449914 | 10.79 |
Gm37709 |
predicted gene, 37709 |
201712 |
0.03 |
chr14_64233778_64233929 | 10.75 |
9630015K15Rik |
RIKEN cDNA 9630015K15 gene |
117539 |
0.05 |
chr13_59148254_59148405 | 10.74 |
Gm34354 |
predicted gene, 34354 |
501 |
0.74 |
chr2_137939077_137939470 | 10.72 |
Gm14062 |
predicted gene 14062 |
62442 |
0.16 |
chr18_81831298_81831489 | 10.72 |
Gm30454 |
predicted gene, 30454 |
18623 |
0.19 |
chr10_15249538_15249689 | 10.70 |
Gm18188 |
predicted gene, 18188 |
21565 |
0.23 |
chr5_113041463_113042083 | 10.65 |
Gm22740 |
predicted gene, 22740 |
2371 |
0.2 |
chr16_52387159_52387325 | 10.64 |
Alcam |
activated leukocyte cell adhesion molecule |
65223 |
0.14 |
chr1_89848298_89848748 | 10.64 |
Gm37521 |
predicted gene, 37521 |
23042 |
0.19 |
chr2_65567228_65567415 | 10.58 |
Scn3a |
sodium channel, voltage-gated, type III, alpha |
171 |
0.96 |
chr3_38884380_38884574 | 10.55 |
Fat4 |
FAT atypical cadherin 4 |
2463 |
0.32 |
chrX_42343522_42343895 | 10.55 |
Gm14619 |
predicted gene 14619 |
3804 |
0.34 |
chr13_20609106_20609281 | 10.52 |
Gm47721 |
predicted gene, 47721 |
36564 |
0.17 |
chr1_132921189_132921408 | 10.50 |
Gm44300 |
predicted gene, 44300 |
2446 |
0.25 |
chr10_33624726_33624916 | 10.49 |
Clvs2 |
clavesin 2 |
52 |
0.9 |
chr3_67309812_67309963 | 10.47 |
Mlf1 |
myeloid leukemia factor 1 |
64210 |
0.11 |
chr6_141495522_141495813 | 10.45 |
Slco1c1 |
solute carrier organic anion transporter family, member 1c1 |
28701 |
0.2 |
chr17_11664742_11664947 | 10.41 |
Gm10513 |
predicted gene 10513 |
67501 |
0.13 |
chr3_34504632_34504783 | 10.40 |
Gm29135 |
predicted gene 29135 |
22500 |
0.16 |
chr13_84751597_84751791 | 10.38 |
Gm26913 |
predicted gene, 26913 |
60753 |
0.15 |
chr7_89046968_89047122 | 10.27 |
Tmem135 |
transmembrane protein 135 |
98452 |
0.08 |
chr16_23258903_23259100 | 10.25 |
St6gal1 |
beta galactoside alpha 2,6 sialyltransferase 1 |
10628 |
0.14 |
chr3_154817331_154817637 | 10.22 |
Gm18589 |
predicted gene, 18589 |
22123 |
0.2 |
chr1_25180650_25181145 | 10.22 |
Adgrb3 |
adhesion G protein-coupled receptor B3 |
23826 |
0.16 |
chr12_29095750_29095939 | 10.22 |
4833405L11Rik |
RIKEN cDNA 4833405L11 gene |
10893 |
0.23 |
chr1_69157499_69157702 | 10.21 |
Gm8840 |
predicted gene 8840 |
26301 |
0.2 |
chr7_123069202_123069353 | 10.19 |
Gm45847 |
predicted gene 45847 |
37783 |
0.12 |
chr2_57916465_57916651 | 10.17 |
Gm33594 |
predicted gene, 33594 |
69459 |
0.11 |
chr9_69844583_69844734 | 10.15 |
Gm18745 |
predicted gene, 18745 |
51507 |
0.13 |
chr13_94376190_94376445 | 10.15 |
Ap3b1 |
adaptor-related protein complex 3, beta 1 subunit |
17357 |
0.17 |
chr12_33225655_33225815 | 10.12 |
Atxn7l1os1 |
ataxin 7-like 1, opposite strand 1 |
3119 |
0.29 |
chr6_40431416_40431824 | 10.12 |
Dennd11 |
DENN domain containing 11 |
212 |
0.91 |
chr8_102575707_102575858 | 10.11 |
Gm45422 |
predicted gene 45422 |
41137 |
0.15 |
chr3_119949650_119949819 | 10.11 |
Gm18384 |
predicted gene, 18384 |
18997 |
0.25 |
chr4_109762760_109763127 | 10.05 |
Gm12808 |
predicted gene 12808 |
8126 |
0.24 |
chr1_20428787_20428938 | 10.05 |
Gm15795 |
predicted gene 15795 |
15948 |
0.17 |
chr18_25548818_25548982 | 10.03 |
Celf4 |
CUGBP, Elav-like family member 4 |
47661 |
0.16 |
chr3_144318847_144319062 | 10.03 |
Gm43447 |
predicted gene 43447 |
1260 |
0.5 |
chrX_93310384_93310605 | 10.01 |
Arx |
aristaless related homeobox |
23984 |
0.21 |
chr6_47175944_47176185 | 9.98 |
Cntnap2 |
contactin associated protein-like 2 |
68323 |
0.13 |
chr4_96968887_96969075 | 9.97 |
Gm27521 |
predicted gene, 27521 |
51961 |
0.15 |
chr5_99062665_99062987 | 9.95 |
Prkg2 |
protein kinase, cGMP-dependent, type II |
25475 |
0.2 |
chr1_4571274_4571491 | 9.92 |
Gm37323 |
predicted gene, 37323 |
14870 |
0.13 |
chr11_90552646_90552797 | 9.91 |
Stxbp4 |
syntaxin binding protein 4 |
3811 |
0.23 |
chr15_86416205_86416356 | 9.86 |
A930001M01Rik |
RIKEN cDNA A930001M01 gene |
58815 |
0.14 |
chr15_10656241_10656392 | 9.82 |
Gm10389 |
predicted gene 10389 |
55979 |
0.1 |
chr2_45225819_45225975 | 9.78 |
Gm28643 |
predicted gene 28643 |
68972 |
0.11 |
chr13_58964694_58965094 | 9.78 |
Ntrk2 |
neurotrophic tyrosine kinase, receptor, type 2 |
93159 |
0.06 |
chr3_84221181_84221332 | 9.77 |
Trim2 |
tripartite motif-containing 2 |
367 |
0.9 |
chr2_102337010_102337185 | 9.77 |
Gm13868 |
predicted gene 13868 |
24890 |
0.21 |
chr3_50421873_50422272 | 9.71 |
Gm37498 |
predicted gene, 37498 |
17789 |
0.21 |
chr2_18731674_18731995 | 9.71 |
Gm13333 |
predicted gene 13333 |
27150 |
0.12 |
chr16_62686085_62686411 | 9.68 |
Gm9816 |
predicted pseudogene 9816 |
30789 |
0.18 |
chr12_55536845_55537032 | 9.66 |
Aldoart2 |
aldolase 1 A, retrogene 2 |
28301 |
0.14 |
chr11_93560626_93560915 | 9.65 |
Gm11502 |
predicted gene 11502 |
89989 |
0.09 |
chr17_25561859_25562047 | 9.60 |
Gm50026 |
predicted gene, 50026 |
740 |
0.43 |
chr13_77396463_77396675 | 9.59 |
Gm9634 |
predicted gene 9634 |
157804 |
0.04 |
chr4_54371542_54371700 | 9.58 |
Gm12469 |
predicted gene 12469 |
135745 |
0.05 |
chr10_45009704_45010027 | 9.57 |
Gm4795 |
predicted pseudogene 4795 |
3755 |
0.21 |
chr7_84113348_84113499 | 9.51 |
Cemip |
cell migration inducing protein, hyaluronan binding |
26921 |
0.14 |
chr7_96595597_96595770 | 9.49 |
Gm15414 |
predicted gene 15414 |
33386 |
0.19 |
chr2_118995596_118995756 | 9.49 |
Gm14089 |
predicted gene 14089 |
1392 |
0.32 |
chr3_101343856_101344007 | 9.48 |
Gm43467 |
predicted gene 43467 |
33085 |
0.11 |
chr8_54836687_54836851 | 9.48 |
n-R5s98 |
nuclear encoded rRNA 5S 98 |
29492 |
0.18 |
chr3_119948986_119949555 | 9.47 |
Gm18384 |
predicted gene, 18384 |
19461 |
0.25 |
chr7_119363899_119364114 | 9.46 |
Gm23321 |
predicted gene, 23321 |
57758 |
0.1 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
5.9 | 23.6 | GO:0051611 | negative regulation of neurotransmitter uptake(GO:0051581) regulation of serotonin uptake(GO:0051611) negative regulation of serotonin uptake(GO:0051612) |
4.5 | 13.5 | GO:0097118 | neuroligin clustering involved in postsynaptic membrane assembly(GO:0097118) |
3.5 | 10.5 | GO:0046684 | response to pyrethroid(GO:0046684) |
2.5 | 7.6 | GO:0032289 | central nervous system myelin formation(GO:0032289) |
2.2 | 8.6 | GO:0030035 | microspike assembly(GO:0030035) |
1.9 | 7.6 | GO:0007412 | axon target recognition(GO:0007412) |
1.9 | 5.7 | GO:0075509 | receptor-mediated endocytosis of virus by host cell(GO:0019065) endocytosis involved in viral entry into host cell(GO:0075509) |
1.9 | 7.5 | GO:0035934 | corticosterone secretion(GO:0035934) regulation of corticosterone secretion(GO:2000852) |
1.8 | 5.5 | GO:0002121 | inter-male aggressive behavior(GO:0002121) |
1.7 | 5.1 | GO:2000821 | regulation of grooming behavior(GO:2000821) |
1.7 | 5.0 | GO:0035609 | C-terminal protein deglutamylation(GO:0035609) |
1.7 | 6.6 | GO:0043313 | regulation of neutrophil degranulation(GO:0043313) |
1.6 | 4.9 | GO:0090158 | endoplasmic reticulum membrane organization(GO:0090158) |
1.6 | 16.3 | GO:0047497 | establishment of mitochondrion localization, microtubule-mediated(GO:0034643) mitochondrion transport along microtubule(GO:0047497) |
1.6 | 4.8 | GO:0015746 | tricarboxylic acid transport(GO:0006842) citrate transport(GO:0015746) |
1.6 | 4.7 | GO:0021912 | regulation of transcription from RNA polymerase II promoter involved in spinal cord motor neuron fate specification(GO:0021912) |
1.5 | 4.6 | GO:1901529 | positive regulation of anion channel activity(GO:1901529) |
1.5 | 4.6 | GO:0072137 | condensed mesenchymal cell proliferation(GO:0072137) |
1.5 | 9.1 | GO:0098598 | vocal learning(GO:0042297) imitative learning(GO:0098596) learned vocalization behavior or vocal learning(GO:0098598) |
1.4 | 4.3 | GO:1990123 | L-glutamate(1-) import into cell(GO:1903802) L-glutamate import into cell(GO:1990123) |
1.3 | 6.6 | GO:0032488 | Cdc42 protein signal transduction(GO:0032488) |
1.3 | 3.9 | GO:0048682 | axon extension involved in regeneration(GO:0048677) sprouting of injured axon(GO:0048682) |
1.3 | 3.8 | GO:2000111 | positive regulation of macrophage apoptotic process(GO:2000111) |
1.3 | 8.8 | GO:0042118 | endothelial cell activation(GO:0042118) |
1.2 | 9.9 | GO:0021830 | interneuron migration from the subpallium to the cortex(GO:0021830) |
1.2 | 2.5 | GO:0000720 | pyrimidine dimer repair by nucleotide-excision repair(GO:0000720) |
1.2 | 3.7 | GO:0060178 | regulation of exocyst localization(GO:0060178) |
1.2 | 7.4 | GO:0021902 | commitment of neuronal cell to specific neuron type in forebrain(GO:0021902) |
1.2 | 2.3 | GO:0046101 | hypoxanthine metabolic process(GO:0046100) hypoxanthine biosynthetic process(GO:0046101) |
1.1 | 3.4 | GO:2001170 | negative regulation of ATP biosynthetic process(GO:2001170) |
1.1 | 3.2 | GO:0031296 | B cell costimulation(GO:0031296) |
1.1 | 4.3 | GO:1903977 | positive regulation of glial cell migration(GO:1903977) |
1.0 | 2.0 | GO:1902498 | regulation of protein autoubiquitination(GO:1902498) |
1.0 | 2.9 | GO:0099558 | maintenance of synapse structure(GO:0099558) |
1.0 | 2.0 | GO:0089700 | protein kinase D signaling(GO:0089700) |
1.0 | 1.9 | GO:0097113 | AMPA glutamate receptor clustering(GO:0097113) glutamate receptor clustering(GO:0097688) |
1.0 | 1.0 | GO:0070777 | D-aspartate transport(GO:0070777) D-aspartate import(GO:0070779) |
0.9 | 3.7 | GO:0006166 | purine ribonucleoside salvage(GO:0006166) |
0.9 | 6.4 | GO:0048681 | negative regulation of axon regeneration(GO:0048681) |
0.9 | 3.5 | GO:0089711 | L-glutamate transmembrane transport(GO:0089711) |
0.9 | 2.6 | GO:1990034 | calcium ion export from cell(GO:1990034) |
0.9 | 5.2 | GO:0048852 | diencephalon morphogenesis(GO:0048852) |
0.9 | 5.1 | GO:0021957 | corticospinal tract morphogenesis(GO:0021957) |
0.8 | 2.5 | GO:1900825 | regulation of membrane depolarization during cardiac muscle cell action potential(GO:1900825) |
0.8 | 2.5 | GO:0044339 | canonical Wnt signaling pathway involved in osteoblast differentiation(GO:0044339) |
0.8 | 3.3 | GO:0033563 | dorsal/ventral axon guidance(GO:0033563) |
0.8 | 2.5 | GO:0021882 | regulation of transcription from RNA polymerase II promoter involved in forebrain neuron fate commitment(GO:0021882) |
0.8 | 2.5 | GO:0018197 | peptidyl-aspartic acid modification(GO:0018197) |
0.8 | 2.5 | GO:0061355 | Wnt protein secretion(GO:0061355) regulation of Wnt protein secretion(GO:0061356) |
0.8 | 4.8 | GO:0006307 | DNA dealkylation involved in DNA repair(GO:0006307) |
0.8 | 3.9 | GO:0097105 | presynaptic membrane assembly(GO:0097105) |
0.8 | 2.3 | GO:2000686 | regulation of rubidium ion transmembrane transporter activity(GO:2000686) |
0.8 | 3.1 | GO:0021914 | negative regulation of smoothened signaling pathway involved in ventral spinal cord patterning(GO:0021914) |
0.8 | 3.8 | GO:0060729 | intestinal epithelial structure maintenance(GO:0060729) |
0.8 | 2.3 | GO:0070093 | negative regulation of glucagon secretion(GO:0070093) |
0.8 | 3.1 | GO:0018343 | protein farnesylation(GO:0018343) |
0.8 | 5.4 | GO:0016198 | axon choice point recognition(GO:0016198) |
0.7 | 3.7 | GO:0097151 | positive regulation of inhibitory postsynaptic potential(GO:0097151) |
0.7 | 2.2 | GO:0052203 | modulation of catalytic activity in other organism involved in symbiotic interaction(GO:0052203) modulation by host of symbiont catalytic activity(GO:0052422) |
0.7 | 0.7 | GO:1901166 | trunk segmentation(GO:0035290) trunk neural crest cell migration(GO:0036484) ventral trunk neural crest cell migration(GO:0036486) sympathetic neuron projection extension(GO:0097490) sympathetic neuron projection guidance(GO:0097491) neural crest cell migration involved in autonomic nervous system development(GO:1901166) |
0.7 | 4.3 | GO:1901897 | regulation of relaxation of cardiac muscle(GO:1901897) |
0.7 | 1.4 | GO:0097155 | fasciculation of sensory neuron axon(GO:0097155) |
0.7 | 3.6 | GO:1903215 | negative regulation of protein targeting to mitochondrion(GO:1903215) |
0.7 | 4.9 | GO:0071625 | vocalization behavior(GO:0071625) |
0.7 | 1.4 | GO:0003331 | regulation of extracellular matrix constituent secretion(GO:0003330) positive regulation of extracellular matrix constituent secretion(GO:0003331) |
0.7 | 3.4 | GO:0014816 | skeletal muscle satellite cell differentiation(GO:0014816) |
0.7 | 1.4 | GO:0048880 | sensory system development(GO:0048880) |
0.7 | 2.0 | GO:0015803 | branched-chain amino acid transport(GO:0015803) leucine transport(GO:0015820) |
0.7 | 1.4 | GO:0003358 | noradrenergic neuron development(GO:0003358) |
0.7 | 2.7 | GO:0048007 | antigen processing and presentation of lipid antigen via MHC class Ib(GO:0048003) antigen processing and presentation, exogenous lipid antigen via MHC class Ib(GO:0048007) |
0.7 | 1.3 | GO:0043490 | malate-aspartate shuttle(GO:0043490) |
0.7 | 1.3 | GO:0003192 | mitral valve formation(GO:0003192) |
0.7 | 2.7 | GO:0009957 | epidermal cell fate specification(GO:0009957) |
0.7 | 5.3 | GO:0048387 | negative regulation of retinoic acid receptor signaling pathway(GO:0048387) |
0.7 | 5.3 | GO:0086036 | regulation of cardiac muscle cell membrane potential(GO:0086036) |
0.6 | 3.2 | GO:0060666 | dichotomous subdivision of terminal units involved in salivary gland branching(GO:0060666) |
0.6 | 8.9 | GO:0006895 | Golgi to endosome transport(GO:0006895) |
0.6 | 0.6 | GO:0061642 | chemoattraction of axon(GO:0061642) |
0.6 | 9.5 | GO:0031290 | retinal ganglion cell axon guidance(GO:0031290) |
0.6 | 2.5 | GO:0071947 | protein deubiquitination involved in ubiquitin-dependent protein catabolic process(GO:0071947) |
0.6 | 4.3 | GO:0008090 | retrograde axonal transport(GO:0008090) |
0.6 | 0.6 | GO:0021631 | optic nerve morphogenesis(GO:0021631) |
0.6 | 3.7 | GO:0071372 | cellular response to follicle-stimulating hormone stimulus(GO:0071372) |
0.6 | 1.8 | GO:0072092 | ureteric bud invasion(GO:0072092) |
0.6 | 2.4 | GO:0051387 | negative regulation of neurotrophin TRK receptor signaling pathway(GO:0051387) |
0.6 | 3.1 | GO:0060449 | bud elongation involved in lung branching(GO:0060449) |
0.6 | 3.0 | GO:0009052 | pentose-phosphate shunt, non-oxidative branch(GO:0009052) |
0.6 | 1.8 | GO:0021979 | hypothalamus cell differentiation(GO:0021979) |
0.6 | 1.8 | GO:0006741 | NADP biosynthetic process(GO:0006741) |
0.6 | 1.8 | GO:1904694 | negative regulation of vascular smooth muscle contraction(GO:1904694) |
0.6 | 1.8 | GO:0046544 | development of secondary male sexual characteristics(GO:0046544) |
0.6 | 0.6 | GO:0032097 | positive regulation of response to food(GO:0032097) positive regulation of appetite(GO:0032100) |
0.6 | 1.2 | GO:2000586 | regulation of platelet-derived growth factor receptor-beta signaling pathway(GO:2000586) negative regulation of platelet-derived growth factor receptor-beta signaling pathway(GO:2000587) |
0.6 | 0.6 | GO:0046865 | retinol transport(GO:0034633) isoprenoid transport(GO:0046864) terpenoid transport(GO:0046865) |
0.6 | 2.3 | GO:0097475 | motor neuron migration(GO:0097475) spinal cord motor neuron migration(GO:0097476) |
0.6 | 1.2 | GO:0003221 | right ventricular cardiac muscle tissue morphogenesis(GO:0003221) |
0.6 | 1.7 | GO:0006435 | threonyl-tRNA aminoacylation(GO:0006435) |
0.6 | 1.2 | GO:0000101 | sulfur amino acid transport(GO:0000101) |
0.6 | 1.1 | GO:0070094 | positive regulation of glucagon secretion(GO:0070094) |
0.6 | 1.1 | GO:0046122 | purine deoxyribonucleoside metabolic process(GO:0046122) |
0.5 | 1.1 | GO:1900019 | regulation of protein kinase C activity(GO:1900019) positive regulation of protein kinase C activity(GO:1900020) |
0.5 | 4.3 | GO:0021707 | cerebellar granular layer formation(GO:0021684) cerebellar granule cell differentiation(GO:0021707) |
0.5 | 1.1 | GO:0031585 | regulation of inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0031585) |
0.5 | 9.1 | GO:0071475 | cellular hyperosmotic salinity response(GO:0071475) |
0.5 | 0.5 | GO:0060051 | negative regulation of protein glycosylation(GO:0060051) |
0.5 | 2.1 | GO:2000623 | regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000622) negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000623) |
0.5 | 1.6 | GO:0097119 | postsynaptic density protein 95 clustering(GO:0097119) |
0.5 | 0.5 | GO:0061110 | dense core granule biogenesis(GO:0061110) regulation of dense core granule biogenesis(GO:2000705) |
0.5 | 5.7 | GO:0097094 | craniofacial suture morphogenesis(GO:0097094) |
0.5 | 2.6 | GO:2000271 | positive regulation of fibroblast apoptotic process(GO:2000271) |
0.5 | 2.0 | GO:0014894 | response to inactivity(GO:0014854) response to muscle inactivity(GO:0014870) response to muscle inactivity involved in regulation of muscle adaptation(GO:0014877) response to denervation involved in regulation of muscle adaptation(GO:0014894) |
0.5 | 3.9 | GO:0048631 | regulation of skeletal muscle tissue growth(GO:0048631) |
0.5 | 1.0 | GO:2000698 | positive regulation of epithelial cell differentiation involved in kidney development(GO:2000698) |
0.5 | 1.9 | GO:0021960 | anterior commissure morphogenesis(GO:0021960) |
0.5 | 1.0 | GO:1902261 | positive regulation of delayed rectifier potassium channel activity(GO:1902261) positive regulation of voltage-gated potassium channel activity(GO:1903818) |
0.5 | 1.4 | GO:0051103 | DNA ligation involved in DNA repair(GO:0051103) |
0.5 | 1.0 | GO:0014724 | regulation of twitch skeletal muscle contraction(GO:0014724) |
0.5 | 4.7 | GO:0017121 | phospholipid scrambling(GO:0017121) |
0.5 | 0.5 | GO:0072197 | ureter morphogenesis(GO:0072197) |
0.5 | 4.2 | GO:0031536 | positive regulation of exit from mitosis(GO:0031536) |
0.5 | 0.9 | GO:0035860 | glial cell-derived neurotrophic factor receptor signaling pathway(GO:0035860) |
0.5 | 2.3 | GO:0060371 | regulation of atrial cardiac muscle cell membrane depolarization(GO:0060371) |
0.5 | 1.4 | GO:0097503 | sialylation(GO:0097503) |
0.5 | 0.5 | GO:0001661 | conditioned taste aversion(GO:0001661) |
0.5 | 4.1 | GO:0060134 | prepulse inhibition(GO:0060134) |
0.5 | 2.3 | GO:0090394 | negative regulation of excitatory postsynaptic potential(GO:0090394) |
0.4 | 3.1 | GO:0005513 | detection of calcium ion(GO:0005513) |
0.4 | 0.4 | GO:0061031 | endodermal digestive tract morphogenesis(GO:0061031) |
0.4 | 1.3 | GO:0035582 | sequestering of BMP in extracellular matrix(GO:0035582) |
0.4 | 2.6 | GO:0015884 | folic acid transport(GO:0015884) |
0.4 | 2.6 | GO:0051461 | positive regulation of corticotropin secretion(GO:0051461) |
0.4 | 2.2 | GO:0016576 | histone dephosphorylation(GO:0016576) |
0.4 | 1.3 | GO:1900245 | positive regulation of MDA-5 signaling pathway(GO:1900245) |
0.4 | 1.3 | GO:0072235 | distal convoluted tubule development(GO:0072025) DCT cell differentiation(GO:0072069) metanephric distal convoluted tubule development(GO:0072221) metanephric distal tubule development(GO:0072235) metanephric DCT cell differentiation(GO:0072240) |
0.4 | 2.6 | GO:0014054 | positive regulation of gamma-aminobutyric acid secretion(GO:0014054) |
0.4 | 1.3 | GO:0001927 | exocyst assembly(GO:0001927) |
0.4 | 9.9 | GO:0007616 | long-term memory(GO:0007616) |
0.4 | 2.6 | GO:1901841 | regulation of high voltage-gated calcium channel activity(GO:1901841) |
0.4 | 0.4 | GO:0021540 | corpus callosum morphogenesis(GO:0021540) |
0.4 | 2.1 | GO:0035426 | extracellular matrix-cell signaling(GO:0035426) |
0.4 | 2.5 | GO:0002091 | negative regulation of receptor internalization(GO:0002091) |
0.4 | 0.8 | GO:0042322 | negative regulation of circadian sleep/wake cycle, REM sleep(GO:0042322) |
0.4 | 3.7 | GO:0043653 | mitochondrial fragmentation involved in apoptotic process(GO:0043653) |
0.4 | 1.2 | GO:0060741 | prostate gland stromal morphogenesis(GO:0060741) |
0.4 | 1.6 | GO:0002051 | osteoblast fate commitment(GO:0002051) |
0.4 | 3.6 | GO:0035745 | T-helper 2 cell cytokine production(GO:0035745) |
0.4 | 2.0 | GO:2001280 | positive regulation of prostaglandin biosynthetic process(GO:0031394) positive regulation of unsaturated fatty acid biosynthetic process(GO:2001280) |
0.4 | 0.8 | GO:0060221 | retinal rod cell differentiation(GO:0060221) |
0.4 | 1.2 | GO:0006562 | proline catabolic process(GO:0006562) |
0.4 | 2.4 | GO:0099515 | actin filament-based transport(GO:0099515) |
0.4 | 2.0 | GO:1903887 | motile primary cilium assembly(GO:1903887) |
0.4 | 1.9 | GO:0036289 | peptidyl-serine autophosphorylation(GO:0036289) |
0.4 | 2.7 | GO:0021952 | central nervous system projection neuron axonogenesis(GO:0021952) |
0.4 | 3.4 | GO:0048280 | vesicle fusion with Golgi apparatus(GO:0048280) |
0.4 | 1.1 | GO:0045196 | establishment or maintenance of neuroblast polarity(GO:0045196) establishment of neuroblast polarity(GO:0045200) |
0.4 | 1.1 | GO:0060825 | fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation(GO:0060825) regulation of fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation(GO:2000313) |
0.4 | 1.1 | GO:0060174 | limb bud formation(GO:0060174) |
0.4 | 0.7 | GO:0035984 | response to trichostatin A(GO:0035983) cellular response to trichostatin A(GO:0035984) |
0.4 | 1.1 | GO:0015889 | cobalamin transport(GO:0015889) |
0.4 | 0.4 | GO:0071674 | mononuclear cell migration(GO:0071674) |
0.4 | 2.5 | GO:0048341 | paraxial mesoderm formation(GO:0048341) |
0.4 | 2.9 | GO:0002318 | myeloid progenitor cell differentiation(GO:0002318) |
0.4 | 1.1 | GO:0090283 | regulation of protein glycosylation in Golgi(GO:0090283) |
0.4 | 1.5 | GO:0070345 | negative regulation of fat cell proliferation(GO:0070345) |
0.4 | 1.4 | GO:0021797 | forebrain anterior/posterior pattern specification(GO:0021797) |
0.4 | 1.1 | GO:0034184 | positive regulation of maintenance of sister chromatid cohesion(GO:0034093) positive regulation of maintenance of mitotic sister chromatid cohesion(GO:0034184) |
0.3 | 1.0 | GO:0072695 | negative regulation of DNA recombination at telomere(GO:0048239) regulation of DNA recombination at telomere(GO:0072695) |
0.3 | 0.7 | GO:0061743 | motor learning(GO:0061743) |
0.3 | 4.4 | GO:0003334 | keratinocyte development(GO:0003334) |
0.3 | 0.3 | GO:0061551 | trigeminal ganglion development(GO:0061551) |
0.3 | 1.0 | GO:0019478 | D-amino acid catabolic process(GO:0019478) |
0.3 | 1.0 | GO:1902774 | late endosome to lysosome transport(GO:1902774) |
0.3 | 3.0 | GO:0006273 | lagging strand elongation(GO:0006273) |
0.3 | 1.3 | GO:0010940 | positive regulation of necrotic cell death(GO:0010940) |
0.3 | 1.0 | GO:0010982 | regulation of high-density lipoprotein particle clearance(GO:0010982) |
0.3 | 1.0 | GO:0032808 | lacrimal gland development(GO:0032808) |
0.3 | 4.9 | GO:0016486 | peptide hormone processing(GO:0016486) |
0.3 | 1.0 | GO:0070427 | nucleotide-binding oligomerization domain containing 1 signaling pathway(GO:0070427) |
0.3 | 0.3 | GO:0051654 | establishment of mitochondrion localization(GO:0051654) |
0.3 | 0.6 | GO:0002282 | microglial cell activation involved in immune response(GO:0002282) |
0.3 | 1.6 | GO:0015808 | L-alanine transport(GO:0015808) |
0.3 | 0.3 | GO:0090258 | negative regulation of mitochondrial fission(GO:0090258) |
0.3 | 4.1 | GO:0021871 | forebrain regionalization(GO:0021871) |
0.3 | 0.9 | GO:1903899 | positive regulation of PERK-mediated unfolded protein response(GO:1903899) |
0.3 | 1.9 | GO:2000672 | negative regulation of motor neuron apoptotic process(GO:2000672) |
0.3 | 1.6 | GO:0097343 | ripoptosome assembly(GO:0097343) ripoptosome assembly involved in necroptotic process(GO:1901026) |
0.3 | 1.2 | GO:0050957 | equilibrioception(GO:0050957) |
0.3 | 0.9 | GO:0071492 | cellular response to UV-A(GO:0071492) |
0.3 | 1.2 | GO:0035627 | ceramide transport(GO:0035627) |
0.3 | 0.9 | GO:0014707 | branchiomeric skeletal muscle development(GO:0014707) |
0.3 | 0.9 | GO:0071288 | cellular response to mercury ion(GO:0071288) |
0.3 | 0.9 | GO:0048818 | positive regulation of hair follicle maturation(GO:0048818) |
0.3 | 0.9 | GO:1903416 | response to glycoside(GO:1903416) |
0.3 | 1.2 | GO:0006642 | triglyceride mobilization(GO:0006642) |
0.3 | 0.6 | GO:0021564 | vagus nerve development(GO:0021564) |
0.3 | 0.3 | GO:0035359 | negative regulation of peroxisome proliferator activated receptor signaling pathway(GO:0035359) |
0.3 | 0.3 | GO:0043396 | corticotropin-releasing hormone secretion(GO:0043396) regulation of corticotropin-releasing hormone secretion(GO:0043397) positive regulation of corticotropin-releasing hormone secretion(GO:0051466) |
0.3 | 0.6 | GO:2000048 | negative regulation of cell-cell adhesion mediated by cadherin(GO:2000048) |
0.3 | 0.8 | GO:0042726 | flavin-containing compound metabolic process(GO:0042726) |
0.3 | 4.7 | GO:0016339 | calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0016339) |
0.3 | 0.6 | GO:0070100 | negative regulation of chemokine-mediated signaling pathway(GO:0070100) |
0.3 | 0.6 | GO:0071677 | positive regulation of mononuclear cell migration(GO:0071677) |
0.3 | 0.8 | GO:0035995 | detection of muscle stretch(GO:0035995) |
0.3 | 0.5 | GO:0033693 | neurofilament bundle assembly(GO:0033693) |
0.3 | 0.3 | GO:0019086 | late viral transcription(GO:0019086) |
0.3 | 0.8 | GO:0048294 | negative regulation of isotype switching to IgE isotypes(GO:0048294) |
0.3 | 0.3 | GO:0061343 | cell adhesion involved in heart morphogenesis(GO:0061343) |
0.3 | 1.3 | GO:0007406 | negative regulation of neuroblast proliferation(GO:0007406) |
0.3 | 2.3 | GO:0016082 | synaptic vesicle priming(GO:0016082) |
0.3 | 0.5 | GO:0003190 | atrioventricular valve formation(GO:0003190) |
0.3 | 1.3 | GO:1902993 | positive regulation of beta-amyloid formation(GO:1902004) positive regulation of amyloid precursor protein catabolic process(GO:1902993) |
0.3 | 3.8 | GO:0006516 | glycoprotein catabolic process(GO:0006516) |
0.3 | 0.8 | GO:0019805 | quinolinate biosynthetic process(GO:0019805) |
0.3 | 0.5 | GO:0060385 | axonogenesis involved in innervation(GO:0060385) |
0.3 | 1.8 | GO:0006108 | malate metabolic process(GO:0006108) |
0.2 | 0.5 | GO:0006295 | nucleotide-excision repair, DNA incision, 3'-to lesion(GO:0006295) |
0.2 | 0.7 | GO:0007089 | traversing start control point of mitotic cell cycle(GO:0007089) |
0.2 | 1.0 | GO:0033353 | S-adenosylmethionine cycle(GO:0033353) |
0.2 | 4.0 | GO:0050908 | detection of light stimulus involved in visual perception(GO:0050908) detection of light stimulus involved in sensory perception(GO:0050962) |
0.2 | 0.9 | GO:1904996 | positive regulation of leukocyte adhesion to vascular endothelial cell(GO:1904996) |
0.2 | 0.9 | GO:0060287 | epithelial cilium movement involved in determination of left/right asymmetry(GO:0060287) |
0.2 | 1.6 | GO:0090331 | negative regulation of platelet aggregation(GO:0090331) |
0.2 | 0.5 | GO:0007158 | neuron cell-cell adhesion(GO:0007158) |
0.2 | 3.0 | GO:0010842 | retina layer formation(GO:0010842) |
0.2 | 2.7 | GO:0007213 | G-protein coupled acetylcholine receptor signaling pathway(GO:0007213) |
0.2 | 0.7 | GO:0060605 | tube lumen cavitation(GO:0060605) salivary gland cavitation(GO:0060662) |
0.2 | 2.3 | GO:0010839 | negative regulation of keratinocyte proliferation(GO:0010839) |
0.2 | 1.8 | GO:1901407 | regulation of phosphorylation of RNA polymerase II C-terminal domain(GO:1901407) positive regulation of phosphorylation of RNA polymerase II C-terminal domain(GO:1901409) |
0.2 | 0.7 | GO:0048550 | negative regulation of pinocytosis(GO:0048550) |
0.2 | 0.5 | GO:0045085 | negative regulation of interleukin-2 biosynthetic process(GO:0045085) |
0.2 | 0.4 | GO:0050862 | positive regulation of T cell receptor signaling pathway(GO:0050862) |
0.2 | 1.3 | GO:0006685 | sphingomyelin catabolic process(GO:0006685) |
0.2 | 5.8 | GO:0032728 | positive regulation of interferon-beta production(GO:0032728) |
0.2 | 0.7 | GO:0043152 | induction of bacterial agglutination(GO:0043152) |
0.2 | 0.4 | GO:0045900 | negative regulation of translational elongation(GO:0045900) |
0.2 | 0.9 | GO:1900452 | regulation of long term synaptic depression(GO:1900452) |
0.2 | 2.0 | GO:0042136 | neurotransmitter biosynthetic process(GO:0042136) |
0.2 | 0.4 | GO:0033578 | protein glycosylation in Golgi(GO:0033578) |
0.2 | 0.6 | GO:0061366 | behavioral response to chemical pain(GO:0061366) behavioral response to formalin induced pain(GO:0061368) |
0.2 | 0.6 | GO:0060618 | nipple development(GO:0060618) |
0.2 | 0.2 | GO:1904339 | negative regulation of dopaminergic neuron differentiation(GO:1904339) |
0.2 | 0.6 | GO:0023041 | neuronal signal transduction(GO:0023041) |
0.2 | 0.6 | GO:0042126 | nitrate metabolic process(GO:0042126) |
0.2 | 0.6 | GO:1901077 | regulation of relaxation of muscle(GO:1901077) |
0.2 | 0.6 | GO:0060005 | vestibular reflex(GO:0060005) |
0.2 | 2.3 | GO:0021889 | olfactory bulb interneuron differentiation(GO:0021889) |
0.2 | 0.2 | GO:0003175 | tricuspid valve development(GO:0003175) |
0.2 | 13.0 | GO:0007156 | homophilic cell adhesion via plasma membrane adhesion molecules(GO:0007156) |
0.2 | 0.2 | GO:1902255 | positive regulation of intrinsic apoptotic signaling pathway by p53 class mediator(GO:1902255) |
0.2 | 0.6 | GO:0006177 | GMP biosynthetic process(GO:0006177) |
0.2 | 0.4 | GO:0072318 | clathrin coat disassembly(GO:0072318) |
0.2 | 1.2 | GO:1900113 | negative regulation of histone H3-K9 trimethylation(GO:1900113) |
0.2 | 1.0 | GO:0032196 | transposition(GO:0032196) |
0.2 | 1.4 | GO:0097066 | response to thyroid hormone(GO:0097066) |
0.2 | 0.8 | GO:2000255 | negative regulation of male germ cell proliferation(GO:2000255) |
0.2 | 8.9 | GO:0051965 | positive regulation of synapse assembly(GO:0051965) |
0.2 | 0.4 | GO:0048861 | leukemia inhibitory factor signaling pathway(GO:0048861) |
0.2 | 0.8 | GO:0051725 | protein de-ADP-ribosylation(GO:0051725) |
0.2 | 1.3 | GO:0000712 | resolution of meiotic recombination intermediates(GO:0000712) |
0.2 | 0.2 | GO:0097090 | presynaptic membrane organization(GO:0097090) |
0.2 | 0.6 | GO:0009173 | UMP biosynthetic process(GO:0006222) pyrimidine ribonucleoside monophosphate metabolic process(GO:0009173) pyrimidine ribonucleoside monophosphate biosynthetic process(GO:0009174) UMP metabolic process(GO:0046049) |
0.2 | 0.6 | GO:0032483 | regulation of Rab protein signal transduction(GO:0032483) |
0.2 | 1.5 | GO:0001956 | positive regulation of neurotransmitter secretion(GO:0001956) |
0.2 | 0.6 | GO:0002074 | extraocular skeletal muscle development(GO:0002074) |
0.2 | 0.6 | GO:0061623 | galactose catabolic process via UDP-galactose(GO:0033499) glycolytic process from galactose(GO:0061623) |
0.2 | 2.0 | GO:0006744 | ubiquinone biosynthetic process(GO:0006744) |
0.2 | 0.6 | GO:0070634 | transepithelial ammonium transport(GO:0070634) |
0.2 | 0.5 | GO:0061156 | pulmonary artery morphogenesis(GO:0061156) |
0.2 | 0.9 | GO:1901525 | negative regulation of macromitophagy(GO:1901525) |
0.2 | 0.7 | GO:0006189 | 'de novo' IMP biosynthetic process(GO:0006189) |
0.2 | 0.4 | GO:1900738 | positive regulation of phospholipase C-activating G-protein coupled receptor signaling pathway(GO:1900738) |
0.2 | 0.4 | GO:0035526 | retrograde transport, plasma membrane to Golgi(GO:0035526) |
0.2 | 0.4 | GO:0055059 | asymmetric neuroblast division(GO:0055059) |
0.2 | 0.7 | GO:0070314 | G1 to G0 transition(GO:0070314) |
0.2 | 0.7 | GO:0015760 | hexose phosphate transport(GO:0015712) glucose-6-phosphate transport(GO:0015760) |
0.2 | 0.5 | GO:1904219 | regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904217) positive regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904219) regulation of serine C-palmitoyltransferase activity(GO:1904220) positive regulation of serine C-palmitoyltransferase activity(GO:1904222) |
0.2 | 0.4 | GO:0006624 | vacuolar protein processing(GO:0006624) |
0.2 | 0.3 | GO:0007386 | compartment pattern specification(GO:0007386) |
0.2 | 8.0 | GO:0007040 | lysosome organization(GO:0007040) lytic vacuole organization(GO:0080171) |
0.2 | 0.5 | GO:0035754 | B cell chemotaxis(GO:0035754) |
0.2 | 0.7 | GO:0035735 | intraciliary transport involved in cilium morphogenesis(GO:0035735) |
0.2 | 0.5 | GO:0006046 | N-acetylglucosamine catabolic process(GO:0006046) |
0.2 | 0.5 | GO:0021859 | pyramidal neuron differentiation(GO:0021859) |
0.2 | 1.4 | GO:0001504 | neurotransmitter uptake(GO:0001504) |
0.2 | 2.0 | GO:0044458 | motile cilium assembly(GO:0044458) |
0.2 | 0.7 | GO:0035331 | negative regulation of hippo signaling(GO:0035331) |
0.2 | 0.2 | GO:0021586 | pons maturation(GO:0021586) |
0.2 | 0.5 | GO:0030208 | dermatan sulfate biosynthetic process(GO:0030208) |
0.2 | 0.5 | GO:1903999 | negative regulation of eating behavior(GO:1903999) |
0.2 | 0.3 | GO:0002386 | immune response in mucosal-associated lymphoid tissue(GO:0002386) |
0.2 | 6.1 | GO:0046847 | filopodium assembly(GO:0046847) |
0.2 | 0.6 | GO:0071763 | nuclear membrane organization(GO:0071763) |
0.2 | 1.4 | GO:2000269 | regulation of fibroblast apoptotic process(GO:2000269) |
0.2 | 0.5 | GO:0006235 | dTTP biosynthetic process(GO:0006235) pyrimidine deoxyribonucleoside triphosphate biosynthetic process(GO:0009212) dTTP metabolic process(GO:0046075) |
0.2 | 0.5 | GO:0019249 | lactate biosynthetic process from pyruvate(GO:0019244) lactate biosynthetic process(GO:0019249) |
0.2 | 0.8 | GO:0043415 | positive regulation of skeletal muscle tissue regeneration(GO:0043415) |
0.2 | 0.3 | GO:0033091 | positive regulation of immature T cell proliferation(GO:0033091) positive regulation of immature T cell proliferation in thymus(GO:0033092) |
0.2 | 0.8 | GO:0031620 | regulation of fever generation(GO:0031620) |
0.2 | 0.6 | GO:0033227 | dsRNA transport(GO:0033227) |
0.2 | 1.2 | GO:0000059 | protein import into nucleus, docking(GO:0000059) |
0.2 | 0.2 | GO:2001055 | positive regulation of mesenchymal cell apoptotic process(GO:2001055) |
0.2 | 0.6 | GO:0015015 | heparan sulfate proteoglycan biosynthetic process, enzymatic modification(GO:0015015) |
0.2 | 0.8 | GO:0048739 | cardiac muscle fiber development(GO:0048739) |
0.2 | 0.3 | GO:0061055 | myotome development(GO:0061055) |
0.2 | 1.4 | GO:0071435 | potassium ion export(GO:0071435) |
0.1 | 0.4 | GO:0021794 | thalamus development(GO:0021794) |
0.1 | 0.4 | GO:0000715 | nucleotide-excision repair, DNA damage recognition(GO:0000715) |
0.1 | 0.1 | GO:0070423 | nucleotide-binding oligomerization domain containing signaling pathway(GO:0070423) nucleotide-binding oligomerization domain containing 2 signaling pathway(GO:0070431) |
0.1 | 1.3 | GO:0035428 | hexose transmembrane transport(GO:0035428) |
0.1 | 0.3 | GO:0060046 | regulation of acrosome reaction(GO:0060046) |
0.1 | 0.1 | GO:0072093 | metanephric renal vesicle formation(GO:0072093) |
0.1 | 0.4 | GO:0006543 | glutamine catabolic process(GO:0006543) |
0.1 | 0.1 | GO:1902988 | neurofibrillary tangle assembly(GO:1902988) regulation of neurofibrillary tangle assembly(GO:1902996) |
0.1 | 0.4 | GO:0002322 | B cell proliferation involved in immune response(GO:0002322) |
0.1 | 0.3 | GO:0002331 | pre-B cell allelic exclusion(GO:0002331) |
0.1 | 0.6 | GO:0060398 | regulation of growth hormone receptor signaling pathway(GO:0060398) |
0.1 | 0.3 | GO:0060060 | post-embryonic retina morphogenesis in camera-type eye(GO:0060060) |
0.1 | 1.1 | GO:0071420 | cellular response to histamine(GO:0071420) |
0.1 | 0.3 | GO:0021529 | spinal cord oligodendrocyte cell differentiation(GO:0021529) spinal cord oligodendrocyte cell fate specification(GO:0021530) |
0.1 | 0.3 | GO:0008355 | olfactory learning(GO:0008355) |
0.1 | 3.8 | GO:0043252 | sodium-independent organic anion transport(GO:0043252) |
0.1 | 0.4 | GO:0009240 | isopentenyl diphosphate biosynthetic process(GO:0009240) isopentenyl diphosphate biosynthetic process, mevalonate pathway(GO:0019287) |
0.1 | 0.3 | GO:0010749 | regulation of nitric oxide mediated signal transduction(GO:0010749) negative regulation of nitric oxide mediated signal transduction(GO:0010751) |
0.1 | 0.1 | GO:0045349 | interferon-alpha biosynthetic process(GO:0045349) regulation of interferon-alpha biosynthetic process(GO:0045354) |
0.1 | 0.4 | GO:0019464 | glycine catabolic process(GO:0006546) glycine decarboxylation via glycine cleavage system(GO:0019464) |
0.1 | 1.9 | GO:1901522 | positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus(GO:1901522) |
0.1 | 0.1 | GO:0021776 | smoothened signaling pathway involved in ventral spinal cord interneuron specification(GO:0021775) smoothened signaling pathway involved in spinal cord motor neuron cell fate specification(GO:0021776) |
0.1 | 0.8 | GO:0031119 | tRNA pseudouridine synthesis(GO:0031119) |
0.1 | 0.3 | GO:0090038 | negative regulation of protein kinase C signaling(GO:0090038) |
0.1 | 0.7 | GO:1902308 | regulation of peptidyl-serine dephosphorylation(GO:1902308) |
0.1 | 0.5 | GO:0032224 | positive regulation of synaptic transmission, cholinergic(GO:0032224) |
0.1 | 0.5 | GO:0006432 | phenylalanyl-tRNA aminoacylation(GO:0006432) |
0.1 | 0.3 | GO:0090383 | phagosome acidification(GO:0090383) |
0.1 | 3.2 | GO:0071526 | semaphorin-plexin signaling pathway(GO:0071526) |
0.1 | 0.8 | GO:1902715 | positive regulation of interferon-gamma secretion(GO:1902715) |
0.1 | 0.3 | GO:0090135 | actin filament branching(GO:0090135) |
0.1 | 0.3 | GO:0035992 | tendon cell differentiation(GO:0035990) tendon formation(GO:0035992) |
0.1 | 1.0 | GO:0097531 | mast cell migration(GO:0097531) |
0.1 | 0.3 | GO:0038161 | prolactin signaling pathway(GO:0038161) |
0.1 | 0.5 | GO:0070245 | positive regulation of thymocyte apoptotic process(GO:0070245) |
0.1 | 0.4 | GO:0034983 | peptidyl-lysine deacetylation(GO:0034983) |
0.1 | 0.4 | GO:0048069 | eye pigmentation(GO:0048069) |
0.1 | 0.6 | GO:0022038 | corpus callosum development(GO:0022038) |
0.1 | 0.9 | GO:0006072 | glycerol-3-phosphate metabolic process(GO:0006072) |
0.1 | 0.4 | GO:2000259 | positive regulation of complement activation(GO:0045917) positive regulation of protein activation cascade(GO:2000259) |
0.1 | 0.3 | GO:0048162 | preantral ovarian follicle growth(GO:0001546) multi-layer follicle stage(GO:0048162) |
0.1 | 2.0 | GO:0007157 | heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0007157) |
0.1 | 0.4 | GO:0006597 | spermine biosynthetic process(GO:0006597) |
0.1 | 0.5 | GO:0070474 | positive regulation of uterine smooth muscle contraction(GO:0070474) |
0.1 | 0.4 | GO:0060839 | endothelial cell fate commitment(GO:0060839) |
0.1 | 0.7 | GO:0006123 | mitochondrial electron transport, cytochrome c to oxygen(GO:0006123) |
0.1 | 0.2 | GO:1900186 | negative regulation of clathrin-mediated endocytosis(GO:1900186) |
0.1 | 0.4 | GO:0097527 | necroptotic signaling pathway(GO:0097527) |
0.1 | 0.7 | GO:0046697 | decidualization(GO:0046697) |
0.1 | 0.6 | GO:0018230 | peptidyl-L-cysteine S-palmitoylation(GO:0018230) peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine(GO:0018231) |
0.1 | 0.2 | GO:0050713 | negative regulation of interleukin-1 beta secretion(GO:0050713) |
0.1 | 0.8 | GO:0010642 | negative regulation of platelet-derived growth factor receptor signaling pathway(GO:0010642) |
0.1 | 0.4 | GO:0070366 | regulation of hepatocyte differentiation(GO:0070366) |
0.1 | 0.2 | GO:1902896 | terminal web assembly(GO:1902896) |
0.1 | 0.2 | GO:0001922 | B-1 B cell homeostasis(GO:0001922) |
0.1 | 0.1 | GO:0060800 | regulation of cell differentiation involved in embryonic placenta development(GO:0060800) |
0.1 | 0.6 | GO:2000009 | negative regulation of protein localization to cell surface(GO:2000009) |
0.1 | 1.0 | GO:0006122 | mitochondrial electron transport, ubiquinol to cytochrome c(GO:0006122) |
0.1 | 1.8 | GO:0006491 | N-glycan processing(GO:0006491) |
0.1 | 0.8 | GO:0003203 | endocardial cushion morphogenesis(GO:0003203) |
0.1 | 0.2 | GO:0010360 | negative regulation of anion channel activity(GO:0010360) |
0.1 | 0.2 | GO:0007208 | phospholipase C-activating serotonin receptor signaling pathway(GO:0007208) |
0.1 | 0.3 | GO:0045650 | negative regulation of macrophage differentiation(GO:0045650) |
0.1 | 1.3 | GO:0035879 | lactate transport(GO:0015727) lactate transmembrane transport(GO:0035873) plasma membrane lactate transport(GO:0035879) |
0.1 | 0.3 | GO:0021785 | branchiomotor neuron axon guidance(GO:0021785) |
0.1 | 0.4 | GO:0042699 | follicle-stimulating hormone signaling pathway(GO:0042699) |
0.1 | 0.2 | GO:0035701 | hematopoietic stem cell migration(GO:0035701) |
0.1 | 1.9 | GO:0070208 | protein heterotrimerization(GO:0070208) |
0.1 | 0.1 | GO:1902953 | positive regulation of ER to Golgi vesicle-mediated transport(GO:1902953) |
0.1 | 2.1 | GO:2001014 | regulation of skeletal muscle cell differentiation(GO:2001014) |
0.1 | 0.2 | GO:0016479 | negative regulation of transcription from RNA polymerase I promoter(GO:0016479) |
0.1 | 0.1 | GO:0050847 | progesterone receptor signaling pathway(GO:0050847) |
0.1 | 0.3 | GO:0071225 | cellular response to muramyl dipeptide(GO:0071225) |
0.1 | 1.0 | GO:0048172 | regulation of short-term neuronal synaptic plasticity(GO:0048172) |
0.1 | 0.2 | GO:2000054 | negative regulation of Wnt signaling pathway involved in dorsal/ventral axis specification(GO:2000054) |
0.1 | 0.8 | GO:0010758 | regulation of macrophage chemotaxis(GO:0010758) |
0.1 | 0.4 | GO:0016557 | peroxisome membrane biogenesis(GO:0016557) |
0.1 | 1.5 | GO:0032011 | ARF protein signal transduction(GO:0032011) regulation of ARF protein signal transduction(GO:0032012) |
0.1 | 0.5 | GO:0034238 | macrophage fusion(GO:0034238) |
0.1 | 0.7 | GO:0090520 | sphingolipid mediated signaling pathway(GO:0090520) |
0.1 | 0.2 | GO:0071500 | cellular response to nitrosative stress(GO:0071500) |
0.1 | 0.4 | GO:0042780 | tRNA 3'-end processing(GO:0042780) |
0.1 | 0.8 | GO:0050884 | neuromuscular process controlling posture(GO:0050884) |
0.1 | 0.4 | GO:0045602 | negative regulation of endothelial cell differentiation(GO:0045602) |
0.1 | 0.3 | GO:0061042 | vascular wound healing(GO:0061042) |
0.1 | 0.3 | GO:0044778 | meiotic DNA integrity checkpoint(GO:0044778) |
0.1 | 0.2 | GO:0072683 | T cell extravasation(GO:0072683) |
0.1 | 0.5 | GO:0060158 | phospholipase C-activating dopamine receptor signaling pathway(GO:0060158) |
0.1 | 0.6 | GO:0045792 | negative regulation of cell size(GO:0045792) |
0.1 | 0.7 | GO:0006370 | 7-methylguanosine mRNA capping(GO:0006370) |
0.1 | 0.1 | GO:0060166 | olfactory pit development(GO:0060166) |
0.1 | 0.1 | GO:0033634 | positive regulation of cell-cell adhesion mediated by integrin(GO:0033634) |
0.1 | 0.1 | GO:0097112 | gamma-aminobutyric acid receptor clustering(GO:0097112) |
0.1 | 0.4 | GO:1900864 | mitochondrial tRNA modification(GO:0070900) mitochondrial RNA modification(GO:1900864) |
0.1 | 1.3 | GO:0003417 | growth plate cartilage development(GO:0003417) |
0.1 | 0.4 | GO:0034975 | protein folding in endoplasmic reticulum(GO:0034975) |
0.1 | 0.5 | GO:0060352 | cell adhesion molecule production(GO:0060352) |
0.1 | 1.2 | GO:0030497 | fatty acid elongation(GO:0030497) |
0.1 | 0.7 | GO:0002031 | G-protein coupled receptor internalization(GO:0002031) |
0.1 | 0.7 | GO:0060628 | regulation of ER to Golgi vesicle-mediated transport(GO:0060628) |
0.1 | 1.0 | GO:0043330 | response to exogenous dsRNA(GO:0043330) |
0.1 | 0.9 | GO:0042220 | response to cocaine(GO:0042220) |
0.1 | 0.1 | GO:0035790 | platelet-derived growth factor receptor-alpha signaling pathway(GO:0035790) |
0.1 | 0.8 | GO:0046069 | cGMP catabolic process(GO:0046069) |
0.1 | 0.4 | GO:0006048 | UDP-N-acetylglucosamine biosynthetic process(GO:0006048) |
0.1 | 0.3 | GO:0071596 | ubiquitin-dependent protein catabolic process via the N-end rule pathway(GO:0071596) |
0.1 | 0.1 | GO:0032661 | regulation of interleukin-18 production(GO:0032661) |
0.1 | 0.3 | GO:0038026 | reelin-mediated signaling pathway(GO:0038026) |
0.1 | 0.3 | GO:2000501 | natural killer cell chemotaxis(GO:0035747) regulation of natural killer cell chemotaxis(GO:2000501) |
0.1 | 0.5 | GO:0070257 | positive regulation of mucus secretion(GO:0070257) |
0.1 | 0.3 | GO:0016095 | polyprenol catabolic process(GO:0016095) |
0.1 | 1.9 | GO:0045773 | positive regulation of axon extension(GO:0045773) |
0.1 | 0.3 | GO:0071436 | sodium ion export from cell(GO:0036376) sodium ion export(GO:0071436) |
0.1 | 0.5 | GO:0017196 | N-terminal peptidyl-methionine acetylation(GO:0017196) |
0.1 | 0.2 | GO:0002727 | natural killer cell cytokine production(GO:0002370) regulation of natural killer cell cytokine production(GO:0002727) |
0.1 | 0.2 | GO:0001555 | oocyte growth(GO:0001555) |
0.1 | 0.5 | GO:0035641 | locomotory exploration behavior(GO:0035641) |
0.1 | 0.6 | GO:0034650 | cortisol metabolic process(GO:0034650) |
0.1 | 0.2 | GO:0097195 | pilomotor reflex(GO:0097195) |
0.1 | 0.3 | GO:0031915 | positive regulation of synaptic plasticity(GO:0031915) |
0.1 | 0.3 | GO:0070365 | hepatocyte differentiation(GO:0070365) |
0.1 | 0.7 | GO:0090073 | positive regulation of protein homodimerization activity(GO:0090073) |
0.1 | 0.3 | GO:0090168 | Golgi reassembly(GO:0090168) |
0.1 | 0.3 | GO:0031339 | negative regulation of vesicle fusion(GO:0031339) |
0.1 | 0.1 | GO:0044333 | Wnt signaling pathway involved in digestive tract morphogenesis(GO:0044333) |
0.1 | 0.2 | GO:0060242 | contact inhibition(GO:0060242) negative regulation of cell proliferation involved in contact inhibition(GO:0060244) |
0.1 | 0.6 | GO:2000628 | regulation of miRNA metabolic process(GO:2000628) |
0.1 | 0.1 | GO:0002434 | immune complex clearance(GO:0002434) |
0.1 | 0.1 | GO:0039663 | fusion of virus membrane with host plasma membrane(GO:0019064) membrane fusion involved in viral entry into host cell(GO:0039663) multi-organism membrane fusion(GO:0044800) |
0.1 | 0.8 | GO:0009312 | oligosaccharide biosynthetic process(GO:0009312) |
0.1 | 0.6 | GO:0018095 | protein polyglutamylation(GO:0018095) |
0.1 | 0.4 | GO:0071257 | cellular response to electrical stimulus(GO:0071257) |
0.1 | 0.5 | GO:0006054 | N-acetylneuraminate metabolic process(GO:0006054) |
0.1 | 0.3 | GO:0015074 | DNA integration(GO:0015074) |
0.1 | 0.5 | GO:0035871 | protein K11-linked deubiquitination(GO:0035871) |
0.1 | 0.2 | GO:1903142 | positive regulation of endothelial cell development(GO:1901552) positive regulation of establishment of endothelial barrier(GO:1903142) |
0.1 | 0.2 | GO:0061511 | centriole elongation(GO:0061511) |
0.1 | 0.6 | GO:0010838 | positive regulation of keratinocyte proliferation(GO:0010838) |
0.1 | 0.1 | GO:0010735 | positive regulation of transcription via serum response element binding(GO:0010735) |
0.1 | 0.2 | GO:0070947 | neutrophil mediated killing of fungus(GO:0070947) |
0.1 | 1.3 | GO:0097031 | NADH dehydrogenase complex assembly(GO:0010257) mitochondrial respiratory chain complex I assembly(GO:0032981) mitochondrial respiratory chain complex I biogenesis(GO:0097031) |
0.1 | 0.5 | GO:0015816 | glycine transport(GO:0015816) |
0.1 | 0.5 | GO:0030949 | positive regulation of vascular endothelial growth factor receptor signaling pathway(GO:0030949) |
0.1 | 0.2 | GO:0006524 | alanine catabolic process(GO:0006524) pyruvate family amino acid catabolic process(GO:0009080) |
0.1 | 0.2 | GO:0071651 | positive regulation of chemokine (C-C motif) ligand 5 production(GO:0071651) |
0.1 | 0.1 | GO:0032727 | positive regulation of interferon-alpha production(GO:0032727) |
0.1 | 0.1 | GO:0060154 | cellular process regulating host cell cycle in response to virus(GO:0060154) |
0.1 | 0.1 | GO:0036438 | maintenance of lens transparency(GO:0036438) |
0.1 | 0.2 | GO:0002930 | trabecular meshwork development(GO:0002930) |
0.1 | 0.1 | GO:0045410 | positive regulation of interleukin-6 biosynthetic process(GO:0045410) |
0.1 | 0.1 | GO:0060157 | urinary bladder development(GO:0060157) |
0.1 | 0.3 | GO:0090080 | positive regulation of MAPKKK cascade by fibroblast growth factor receptor signaling pathway(GO:0090080) |
0.1 | 0.5 | GO:0016242 | negative regulation of macroautophagy(GO:0016242) |
0.1 | 0.1 | GO:0071609 | chemokine (C-C motif) ligand 5 production(GO:0071609) |
0.1 | 0.3 | GO:0046607 | positive regulation of centrosome cycle(GO:0046607) |
0.1 | 0.1 | GO:1903715 | regulation of aerobic respiration(GO:1903715) |
0.1 | 0.3 | GO:0000395 | mRNA 5'-splice site recognition(GO:0000395) |
0.1 | 0.2 | GO:0003348 | cardiac endothelial cell differentiation(GO:0003348) |
0.1 | 0.1 | GO:0046881 | positive regulation of follicle-stimulating hormone secretion(GO:0046881) |
0.1 | 0.1 | GO:0044359 | modulation of molecular function in other organism(GO:0044359) negative regulation of molecular function in other organism(GO:0044362) negative regulation of molecular function in other organism involved in symbiotic interaction(GO:0052204) modulation of molecular function in other organism involved in symbiotic interaction(GO:0052205) |
0.1 | 0.2 | GO:0071042 | U1 snRNA 3'-end processing(GO:0034473) U5 snRNA 3'-end processing(GO:0034476) nuclear polyadenylation-dependent mRNA catabolic process(GO:0071042) polyadenylation-dependent mRNA catabolic process(GO:0071047) |
0.1 | 0.3 | GO:0000160 | phosphorelay signal transduction system(GO:0000160) |
0.1 | 0.1 | GO:0001957 | intramembranous ossification(GO:0001957) direct ossification(GO:0036072) |
0.1 | 0.1 | GO:1902956 | regulation of mitochondrial electron transport, NADH to ubiquinone(GO:1902956) |
0.1 | 0.1 | GO:2000074 | regulation of type B pancreatic cell development(GO:2000074) |
0.1 | 0.5 | GO:0001964 | startle response(GO:0001964) |
0.1 | 0.3 | GO:0090435 | protein localization to nuclear envelope(GO:0090435) |
0.1 | 0.8 | GO:0002063 | chondrocyte development(GO:0002063) |
0.1 | 0.4 | GO:0031629 | synaptic vesicle fusion to presynaptic active zone membrane(GO:0031629) vesicle fusion to plasma membrane(GO:0099500) |
0.1 | 0.2 | GO:0060179 | male mating behavior(GO:0060179) |
0.1 | 0.1 | GO:0072513 | positive regulation of secondary heart field cardioblast proliferation(GO:0072513) |
0.1 | 0.1 | GO:0032914 | positive regulation of transforming growth factor beta1 production(GO:0032914) |
0.1 | 0.1 | GO:1901858 | regulation of mitochondrial DNA metabolic process(GO:1901858) |
0.1 | 3.8 | GO:0033138 | positive regulation of peptidyl-serine phosphorylation(GO:0033138) |
0.1 | 0.1 | GO:0030950 | establishment or maintenance of actin cytoskeleton polarity(GO:0030950) |
0.1 | 0.1 | GO:0060648 | mammary gland bud morphogenesis(GO:0060648) |
0.1 | 0.1 | GO:1903358 | regulation of Golgi organization(GO:1903358) |
0.1 | 0.4 | GO:0002591 | positive regulation of antigen processing and presentation of peptide antigen via MHC class I(GO:0002591) |
0.1 | 0.1 | GO:0033625 | positive regulation of integrin activation(GO:0033625) |
0.1 | 0.1 | GO:0017085 | response to insecticide(GO:0017085) |
0.1 | 0.2 | GO:0070120 | ciliary neurotrophic factor-mediated signaling pathway(GO:0070120) |
0.1 | 0.7 | GO:0071480 | cellular response to gamma radiation(GO:0071480) |
0.1 | 0.2 | GO:0019673 | GDP-mannose metabolic process(GO:0019673) |
0.1 | 0.5 | GO:0060074 | synapse maturation(GO:0060074) |
0.1 | 0.3 | GO:0051151 | negative regulation of smooth muscle cell differentiation(GO:0051151) |
0.1 | 0.1 | GO:0072198 | mesenchymal cell proliferation involved in ureter development(GO:0072198) regulation of mesenchymal cell proliferation involved in ureter development(GO:0072199) positive regulation of mesenchymal cell proliferation involved in ureter development(GO:2000729) |
0.1 | 0.2 | GO:0046541 | saliva secretion(GO:0046541) |
0.1 | 0.2 | GO:0070262 | peptidyl-serine dephosphorylation(GO:0070262) |
0.1 | 0.9 | GO:1901379 | regulation of potassium ion transmembrane transport(GO:1901379) |
0.1 | 0.1 | GO:0010649 | regulation of cell communication by electrical coupling(GO:0010649) |
0.1 | 0.3 | GO:0071670 | smooth muscle cell chemotaxis(GO:0071670) |
0.1 | 0.4 | GO:0060736 | prostate gland growth(GO:0060736) |
0.1 | 0.1 | GO:0018894 | dibenzo-p-dioxin metabolic process(GO:0018894) |
0.1 | 0.2 | GO:0010032 | meiotic chromosome condensation(GO:0010032) |
0.1 | 0.4 | GO:0071294 | cellular response to zinc ion(GO:0071294) |
0.1 | 0.4 | GO:0036158 | outer dynein arm assembly(GO:0036158) |
0.1 | 0.2 | GO:0030311 | poly-N-acetyllactosamine metabolic process(GO:0030309) poly-N-acetyllactosamine biosynthetic process(GO:0030311) |
0.1 | 0.1 | GO:2000324 | positive regulation of glucocorticoid receptor signaling pathway(GO:2000324) |
0.1 | 0.3 | GO:0090141 | positive regulation of mitochondrial fission(GO:0090141) |
0.1 | 0.1 | GO:2000680 | regulation of rubidium ion transport(GO:2000680) |
0.1 | 0.1 | GO:1902226 | regulation of macrophage colony-stimulating factor signaling pathway(GO:1902226) regulation of response to macrophage colony-stimulating factor(GO:1903969) regulation of cellular response to macrophage colony-stimulating factor stimulus(GO:1903972) |
0.1 | 0.1 | GO:0071873 | response to norepinephrine(GO:0071873) |
0.1 | 0.5 | GO:0048266 | behavioral response to pain(GO:0048266) |
0.1 | 0.7 | GO:0048026 | positive regulation of mRNA splicing, via spliceosome(GO:0048026) |
0.1 | 0.3 | GO:0006398 | mRNA 3'-end processing by stem-loop binding and cleavage(GO:0006398) |
0.1 | 0.2 | GO:0072051 | juxtaglomerular apparatus development(GO:0072051) |
0.1 | 0.2 | GO:0033314 | mitotic DNA replication checkpoint(GO:0033314) |
0.1 | 0.1 | GO:1903336 | negative regulation of vacuolar transport(GO:1903336) |
0.1 | 0.1 | GO:0070460 | thyroid-stimulating hormone secretion(GO:0070460) |
0.1 | 0.2 | GO:1902626 | assembly of large subunit precursor of preribosome(GO:1902626) |
0.1 | 0.1 | GO:0006975 | DNA damage induced protein phosphorylation(GO:0006975) |
0.1 | 0.1 | GO:0031443 | fast-twitch skeletal muscle fiber contraction(GO:0031443) |
0.1 | 1.6 | GO:0006958 | complement activation, classical pathway(GO:0006958) |
0.1 | 0.2 | GO:0051970 | negative regulation of transmission of nerve impulse(GO:0051970) |
0.1 | 0.2 | GO:0008078 | mesodermal cell migration(GO:0008078) |
0.0 | 0.1 | GO:0010756 | positive regulation of plasminogen activation(GO:0010756) |
0.0 | 0.1 | GO:2001023 | regulation of response to drug(GO:2001023) |
0.0 | 0.2 | GO:2000601 | positive regulation of Arp2/3 complex-mediated actin nucleation(GO:2000601) |
0.0 | 0.0 | GO:0018076 | N-terminal peptidyl-lysine acetylation(GO:0018076) |
0.0 | 0.3 | GO:0009226 | nucleotide-sugar biosynthetic process(GO:0009226) |
0.0 | 0.1 | GO:2000609 | regulation of thyroid hormone generation(GO:2000609) |
0.0 | 0.0 | GO:1902992 | negative regulation of amyloid precursor protein catabolic process(GO:1902992) |
0.0 | 0.1 | GO:0061299 | retina vasculature morphogenesis in camera-type eye(GO:0061299) |
0.0 | 0.2 | GO:0086069 | bundle of His cell to Purkinje myocyte communication(GO:0086069) |
0.0 | 0.9 | GO:0033198 | response to ATP(GO:0033198) |
0.0 | 0.1 | GO:0030222 | eosinophil differentiation(GO:0030222) |
0.0 | 0.1 | GO:0002860 | positive regulation of natural killer cell mediated immune response to tumor cell(GO:0002857) positive regulation of natural killer cell mediated cytotoxicity directed against tumor cell target(GO:0002860) |
0.0 | 0.1 | GO:0042695 | thelarche(GO:0042695) mammary gland branching involved in thelarche(GO:0060744) |
0.0 | 0.1 | GO:0070164 | negative regulation of adiponectin secretion(GO:0070164) |
0.0 | 0.2 | GO:0006627 | protein processing involved in protein targeting to mitochondrion(GO:0006627) |
0.0 | 0.0 | GO:0072584 | caveolin-mediated endocytosis(GO:0072584) |
0.0 | 0.0 | GO:0070092 | regulation of glucagon secretion(GO:0070092) |
0.0 | 0.1 | GO:0016188 | synaptic vesicle maturation(GO:0016188) |
0.0 | 0.0 | GO:0014901 | regulation of satellite cell activation involved in skeletal muscle regeneration(GO:0014717) satellite cell activation involved in skeletal muscle regeneration(GO:0014901) |
0.0 | 0.1 | GO:0033326 | cerebrospinal fluid secretion(GO:0033326) |
0.0 | 0.3 | GO:0000055 | ribosomal large subunit export from nucleus(GO:0000055) |
0.0 | 0.2 | GO:0060384 | innervation(GO:0060384) |
0.0 | 0.3 | GO:0001886 | endothelial cell morphogenesis(GO:0001886) |
0.0 | 0.3 | GO:0007628 | adult walking behavior(GO:0007628) walking behavior(GO:0090659) |
0.0 | 0.2 | GO:0051386 | regulation of neurotrophin TRK receptor signaling pathway(GO:0051386) |
0.0 | 0.1 | GO:0051365 | cellular response to potassium ion starvation(GO:0051365) |
0.0 | 0.1 | GO:0006704 | glucocorticoid biosynthetic process(GO:0006704) |
0.0 | 0.1 | GO:1903265 | positive regulation of tumor necrosis factor-mediated signaling pathway(GO:1903265) |
0.0 | 0.0 | GO:1903797 | positive regulation of inorganic anion transmembrane transport(GO:1903797) |
0.0 | 0.3 | GO:0070633 | transepithelial transport(GO:0070633) |
0.0 | 0.3 | GO:0036119 | response to platelet-derived growth factor(GO:0036119) cellular response to platelet-derived growth factor stimulus(GO:0036120) |
0.0 | 0.2 | GO:0060081 | membrane hyperpolarization(GO:0060081) |
0.0 | 0.1 | GO:0002669 | positive regulation of T cell anergy(GO:0002669) positive regulation of lymphocyte anergy(GO:0002913) |
0.0 | 0.1 | GO:0050968 | detection of chemical stimulus involved in sensory perception of pain(GO:0050968) |
0.0 | 0.1 | GO:0010901 | regulation of very-low-density lipoprotein particle remodeling(GO:0010901) |
0.0 | 0.0 | GO:0021764 | amygdala development(GO:0021764) |
0.0 | 0.1 | GO:0031117 | positive regulation of microtubule depolymerization(GO:0031117) |
0.0 | 0.3 | GO:0071243 | cellular response to arsenic-containing substance(GO:0071243) |
0.0 | 0.1 | GO:0051409 | response to nitrosative stress(GO:0051409) |
0.0 | 0.1 | GO:0007525 | somatic muscle development(GO:0007525) |
0.0 | 0.0 | GO:1901674 | histone H3-K27 acetylation(GO:0043974) regulation of histone H3-K27 acetylation(GO:1901674) |
0.0 | 0.1 | GO:0006930 | substrate-dependent cell migration, cell extension(GO:0006930) |
0.0 | 0.4 | GO:0045954 | positive regulation of natural killer cell mediated cytotoxicity(GO:0045954) |
0.0 | 0.4 | GO:0060997 | dendritic spine morphogenesis(GO:0060997) |
0.0 | 0.4 | GO:1902572 | regulation of serine-type endopeptidase activity(GO:1900003) negative regulation of serine-type endopeptidase activity(GO:1900004) regulation of serine-type peptidase activity(GO:1902571) negative regulation of serine-type peptidase activity(GO:1902572) |
0.0 | 0.1 | GO:1905097 | regulation of guanyl-nucleotide exchange factor activity(GO:1905097) |
0.0 | 0.1 | GO:0002019 | regulation of renal output by angiotensin(GO:0002019) |
0.0 | 0.0 | GO:0061209 | cell proliferation involved in mesonephros development(GO:0061209) |
0.0 | 0.0 | GO:1901421 | positive regulation of response to alcohol(GO:1901421) |
0.0 | 0.1 | GO:0002426 | immunoglobulin production in mucosal tissue(GO:0002426) |
0.0 | 0.1 | GO:0044704 | mating plug formation(GO:0042628) single-organism reproductive behavior(GO:0044704) post-mating behavior(GO:0045297) |
0.0 | 0.1 | GO:0000710 | meiotic mismatch repair(GO:0000710) |
0.0 | 0.1 | GO:0046951 | ketone body biosynthetic process(GO:0046951) |
0.0 | 0.3 | GO:0051127 | positive regulation of actin nucleation(GO:0051127) |
0.0 | 0.1 | GO:0042276 | error-prone translesion synthesis(GO:0042276) |
0.0 | 0.3 | GO:0045836 | positive regulation of meiotic nuclear division(GO:0045836) |
0.0 | 0.0 | GO:0086013 | membrane repolarization during cardiac muscle cell action potential(GO:0086013) |
0.0 | 0.1 | GO:0033564 | anterior/posterior axon guidance(GO:0033564) |
0.0 | 0.1 | GO:0034442 | regulation of lipoprotein oxidation(GO:0034442) negative regulation of lipoprotein oxidation(GO:0034443) |
0.0 | 0.1 | GO:0060988 | lipid tube assembly(GO:0060988) |
0.0 | 0.0 | GO:0090148 | membrane fission(GO:0090148) |
0.0 | 0.1 | GO:0033299 | secretion of lysosomal enzymes(GO:0033299) |
0.0 | 0.0 | GO:0045914 | negative regulation of catecholamine metabolic process(GO:0045914) negative regulation of dopamine metabolic process(GO:0045963) |
0.0 | 0.3 | GO:0045956 | positive regulation of calcium ion-dependent exocytosis(GO:0045956) |
0.0 | 0.0 | GO:0035826 | rubidium ion transport(GO:0035826) |
0.0 | 0.2 | GO:0018026 | peptidyl-lysine monomethylation(GO:0018026) |
0.0 | 0.1 | GO:0018199 | peptidyl-glutamine modification(GO:0018199) |
0.0 | 0.4 | GO:0048168 | regulation of neuronal synaptic plasticity(GO:0048168) |
0.0 | 0.0 | GO:0007195 | adenylate cyclase-inhibiting dopamine receptor signaling pathway(GO:0007195) |
0.0 | 0.1 | GO:0042091 | interleukin-10 biosynthetic process(GO:0042091) regulation of interleukin-10 biosynthetic process(GO:0045074) |
0.0 | 0.1 | GO:0007638 | mechanosensory behavior(GO:0007638) |
0.0 | 0.0 | GO:0003176 | aortic valve development(GO:0003176) aortic valve morphogenesis(GO:0003180) |
0.0 | 0.1 | GO:0032607 | interferon-alpha production(GO:0032607) |
0.0 | 0.1 | GO:0015755 | fructose transport(GO:0015755) |
0.0 | 0.1 | GO:0035542 | regulation of SNARE complex assembly(GO:0035542) |
0.0 | 0.0 | GO:0046490 | isopentenyl diphosphate metabolic process(GO:0046490) |
0.0 | 0.4 | GO:0043268 | positive regulation of potassium ion transport(GO:0043268) |
0.0 | 0.1 | GO:0071499 | response to laminar fluid shear stress(GO:0034616) cellular response to laminar fluid shear stress(GO:0071499) |
0.0 | 0.4 | GO:0060219 | camera-type eye photoreceptor cell differentiation(GO:0060219) |
0.0 | 0.0 | GO:1902563 | regulation of neutrophil activation(GO:1902563) |
0.0 | 0.6 | GO:0035458 | cellular response to interferon-beta(GO:0035458) |
0.0 | 0.1 | GO:2000346 | negative regulation of hepatocyte proliferation(GO:2000346) |
0.0 | 0.1 | GO:0002538 | arachidonic acid metabolite production involved in inflammatory response(GO:0002538) |
0.0 | 0.1 | GO:0050961 | detection of temperature stimulus involved in sensory perception(GO:0050961) detection of temperature stimulus involved in sensory perception of pain(GO:0050965) |
0.0 | 0.1 | GO:0006297 | nucleotide-excision repair, DNA gap filling(GO:0006297) |
0.0 | 0.1 | GO:0000087 | mitotic M phase(GO:0000087) |
0.0 | 0.0 | GO:0001880 | Mullerian duct regression(GO:0001880) |
0.0 | 0.1 | GO:1900273 | positive regulation of long-term synaptic potentiation(GO:1900273) |
0.0 | 0.1 | GO:0060573 | ventral spinal cord interneuron specification(GO:0021521) cell fate specification involved in pattern specification(GO:0060573) |
0.0 | 0.1 | GO:0072718 | response to cisplatin(GO:0072718) |
0.0 | 0.0 | GO:0035106 | operant conditioning(GO:0035106) |
0.0 | 0.0 | GO:0021554 | optic nerve development(GO:0021554) |
0.0 | 0.1 | GO:0006517 | protein deglycosylation(GO:0006517) |
0.0 | 0.1 | GO:1900165 | negative regulation of interleukin-6 secretion(GO:1900165) |
0.0 | 0.1 | GO:0031077 | post-embryonic camera-type eye development(GO:0031077) |
0.0 | 0.1 | GO:0070816 | phosphorylation of RNA polymerase II C-terminal domain(GO:0070816) |
0.0 | 0.0 | GO:0015747 | urate transport(GO:0015747) |
0.0 | 0.0 | GO:0032471 | negative regulation of endoplasmic reticulum calcium ion concentration(GO:0032471) |
0.0 | 0.5 | GO:0048873 | homeostasis of number of cells within a tissue(GO:0048873) |
0.0 | 0.0 | GO:0019371 | cyclooxygenase pathway(GO:0019371) |
0.0 | 0.1 | GO:0010763 | positive regulation of fibroblast migration(GO:0010763) |
0.0 | 0.1 | GO:0072366 | regulation of cellular ketone metabolic process by positive regulation of transcription from RNA polymerase II promoter(GO:0072366) |
0.0 | 0.1 | GO:0031293 | membrane protein intracellular domain proteolysis(GO:0031293) |
0.0 | 0.0 | GO:0031652 | positive regulation of heat generation(GO:0031652) |
0.0 | 0.1 | GO:0030091 | protein repair(GO:0030091) |
0.0 | 0.1 | GO:0014028 | notochord formation(GO:0014028) |
0.0 | 0.0 | GO:0003199 | endocardial cushion to mesenchymal transition involved in heart valve formation(GO:0003199) |
0.0 | 0.1 | GO:0042511 | positive regulation of tyrosine phosphorylation of Stat1 protein(GO:0042511) |
0.0 | 0.1 | GO:0072385 | minus-end-directed organelle transport along microtubule(GO:0072385) |
0.0 | 0.1 | GO:0014722 | regulation of skeletal muscle contraction by calcium ion signaling(GO:0014722) |
0.0 | 0.1 | GO:0002408 | myeloid dendritic cell chemotaxis(GO:0002408) |
0.0 | 0.0 | GO:0048548 | regulation of pinocytosis(GO:0048548) |
0.0 | 0.1 | GO:0018202 | peptidyl-histidine modification(GO:0018202) |
0.0 | 0.0 | GO:0032621 | interleukin-18 production(GO:0032621) |
0.0 | 0.4 | GO:0009268 | response to pH(GO:0009268) |
0.0 | 0.1 | GO:0070525 | tRNA threonylcarbamoyladenosine metabolic process(GO:0070525) |
0.0 | 0.1 | GO:0042182 | ketone catabolic process(GO:0042182) |
0.0 | 0.3 | GO:0086010 | membrane depolarization during action potential(GO:0086010) |
0.0 | 0.1 | GO:0045779 | negative regulation of bone resorption(GO:0045779) |
0.0 | 0.0 | GO:0002036 | regulation of L-glutamate transport(GO:0002036) |
0.0 | 0.2 | GO:0001522 | pseudouridine synthesis(GO:0001522) |
0.0 | 0.2 | GO:1902043 | positive regulation of extrinsic apoptotic signaling pathway via death domain receptors(GO:1902043) |
0.0 | 0.0 | GO:0097694 | establishment of RNA localization to telomere(GO:0097694) |
0.0 | 0.0 | GO:0070973 | protein localization to endoplasmic reticulum exit site(GO:0070973) |
0.0 | 0.0 | GO:0042360 | vitamin E metabolic process(GO:0042360) |
0.0 | 0.1 | GO:0006420 | arginyl-tRNA aminoacylation(GO:0006420) |
0.0 | 0.0 | GO:0060128 | corticotropin hormone secreting cell differentiation(GO:0060128) |
0.0 | 0.0 | GO:0038165 | oncostatin-M-mediated signaling pathway(GO:0038165) |
0.0 | 0.0 | GO:0010248 | establishment or maintenance of transmembrane electrochemical gradient(GO:0010248) |
0.0 | 0.1 | GO:0006198 | cAMP catabolic process(GO:0006198) |
0.0 | 0.0 | GO:0010996 | response to auditory stimulus(GO:0010996) |
0.0 | 0.2 | GO:0045806 | negative regulation of endocytosis(GO:0045806) |
0.0 | 0.2 | GO:0016045 | detection of bacterium(GO:0016045) detection of other organism(GO:0098543) |
0.0 | 0.0 | GO:0034165 | positive regulation of toll-like receptor 9 signaling pathway(GO:0034165) |
0.0 | 0.1 | GO:0034219 | carbohydrate transmembrane transport(GO:0034219) |
0.0 | 0.0 | GO:0018364 | peptidyl-glutamine methylation(GO:0018364) |
0.0 | 0.0 | GO:0016115 | terpenoid catabolic process(GO:0016115) |
0.0 | 0.1 | GO:0097240 | telomere tethering at nuclear periphery(GO:0034398) meiotic telomere tethering at nuclear periphery(GO:0044821) meiotic attachment of telomere to nuclear envelope(GO:0070197) chromosome attachment to the nuclear envelope(GO:0097240) |
0.0 | 0.0 | GO:2000969 | positive regulation of glutamate receptor signaling pathway(GO:1900451) positive regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000969) |
0.0 | 0.0 | GO:1900112 | regulation of histone H3-K9 trimethylation(GO:1900112) |
0.0 | 0.1 | GO:0097320 | membrane tubulation(GO:0097320) |
0.0 | 0.0 | GO:0006667 | sphinganine metabolic process(GO:0006667) |
0.0 | 0.0 | GO:0060478 | acrosomal vesicle exocytosis(GO:0060478) |
0.0 | 0.3 | GO:0035058 | nonmotile primary cilium assembly(GO:0035058) |
0.0 | 0.0 | GO:0030202 | heparin metabolic process(GO:0030202) |
0.0 | 0.0 | GO:1904714 | regulation of chaperone-mediated autophagy(GO:1904714) |
0.0 | 0.1 | GO:0033683 | nucleotide-excision repair, DNA incision(GO:0033683) |
0.0 | 0.0 | GO:0035520 | monoubiquitinated protein deubiquitination(GO:0035520) |
0.0 | 0.0 | GO:2000543 | positive regulation of gastrulation(GO:2000543) |
0.0 | 0.0 | GO:0021854 | hypothalamus development(GO:0021854) |
0.0 | 0.1 | GO:0002093 | auditory receptor cell morphogenesis(GO:0002093) |
0.0 | 0.0 | GO:0030205 | dermatan sulfate metabolic process(GO:0030205) |
0.0 | 0.2 | GO:0016578 | histone deubiquitination(GO:0016578) |
0.0 | 0.0 | GO:2001206 | positive regulation of osteoclast development(GO:2001206) |
0.0 | 0.0 | GO:0071476 | cellular hypotonic response(GO:0071476) |
0.0 | 0.1 | GO:0007210 | serotonin receptor signaling pathway(GO:0007210) |
0.0 | 0.0 | GO:0097242 | beta-amyloid clearance(GO:0097242) |
0.0 | 0.0 | GO:0042891 | antibiotic transport(GO:0042891) |
0.0 | 0.0 | GO:0032066 | nucleolus to nucleoplasm transport(GO:0032066) |
0.0 | 0.0 | GO:1900271 | regulation of long-term synaptic potentiation(GO:1900271) |
0.0 | 0.0 | GO:1902445 | regulation of mitochondrial membrane permeability involved in programmed necrotic cell death(GO:1902445) |
0.0 | 0.1 | GO:0036342 | post-anal tail morphogenesis(GO:0036342) |
0.0 | 0.0 | GO:0031284 | positive regulation of guanylate cyclase activity(GO:0031284) |
0.0 | 0.0 | GO:1900041 | negative regulation of interleukin-2 secretion(GO:1900041) |
0.0 | 0.1 | GO:0006572 | tyrosine catabolic process(GO:0006572) |
0.0 | 0.0 | GO:0035584 | calcium-mediated signaling using intracellular calcium source(GO:0035584) |
0.0 | 0.1 | GO:0035855 | megakaryocyte development(GO:0035855) |
0.0 | 0.0 | GO:0002517 | T cell tolerance induction(GO:0002517) |
0.0 | 0.4 | GO:0050911 | detection of chemical stimulus involved in sensory perception of smell(GO:0050911) |
0.0 | 0.0 | GO:0051665 | membrane raft localization(GO:0051665) |
0.0 | 0.0 | GO:0046959 | habituation(GO:0046959) |
0.0 | 0.0 | GO:0060437 | lung growth(GO:0060437) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.1 | 6.3 | GO:0014701 | junctional sarcoplasmic reticulum membrane(GO:0014701) |
2.0 | 12.0 | GO:0016012 | sarcoglycan complex(GO:0016012) |
1.6 | 4.8 | GO:0060053 | neurofilament cytoskeleton(GO:0060053) |
1.6 | 4.7 | GO:0072534 | perineuronal net(GO:0072534) |
1.1 | 12.8 | GO:0001518 | voltage-gated sodium channel complex(GO:0001518) |
1.0 | 8.1 | GO:0030122 | AP-2 adaptor complex(GO:0030122) |
1.0 | 14.5 | GO:0043196 | varicosity(GO:0043196) |
0.9 | 6.6 | GO:0098563 | integral component of synaptic vesicle membrane(GO:0030285) intrinsic component of synaptic vesicle membrane(GO:0098563) |
0.9 | 2.8 | GO:0005658 | alpha DNA polymerase:primase complex(GO:0005658) |
0.8 | 5.6 | GO:0032584 | growth cone membrane(GO:0032584) |
0.6 | 4.4 | GO:0036057 | filtration diaphragm(GO:0036056) slit diaphragm(GO:0036057) |
0.6 | 2.5 | GO:0032777 | Piccolo NuA4 histone acetyltransferase complex(GO:0032777) |
0.6 | 5.0 | GO:0005890 | sodium:potassium-exchanging ATPase complex(GO:0005890) |
0.6 | 1.9 | GO:0070939 | Dsl1p complex(GO:0070939) |
0.6 | 2.3 | GO:0019815 | B cell receptor complex(GO:0019815) |
0.5 | 4.6 | GO:0043194 | axon initial segment(GO:0043194) |
0.5 | 3.9 | GO:0043083 | synaptic cleft(GO:0043083) |
0.5 | 2.4 | GO:0097433 | dense body(GO:0097433) |
0.5 | 1.4 | GO:0005958 | DNA-dependent protein kinase-DNA ligase 4 complex(GO:0005958) |
0.4 | 1.3 | GO:0005594 | collagen type IX trimer(GO:0005594) |
0.4 | 2.2 | GO:0044294 | dendritic growth cone(GO:0044294) |
0.4 | 0.8 | GO:0030121 | AP-1 adaptor complex(GO:0030121) |
0.4 | 22.9 | GO:0043198 | dendritic shaft(GO:0043198) |
0.4 | 7.1 | GO:0060077 | inhibitory synapse(GO:0060077) |
0.4 | 1.6 | GO:0033010 | paranodal junction(GO:0033010) |
0.4 | 3.5 | GO:0035253 | ciliary rootlet(GO:0035253) |
0.4 | 4.2 | GO:0030061 | mitochondrial crista(GO:0030061) |
0.4 | 4.6 | GO:0030673 | axolemma(GO:0030673) |
0.4 | 1.5 | GO:0002189 | ribose phosphate diphosphokinase complex(GO:0002189) |
0.3 | 3.4 | GO:0042622 | photoreceptor outer segment membrane(GO:0042622) |
0.3 | 1.0 | GO:0005944 | phosphatidylinositol 3-kinase complex, class IB(GO:0005944) |
0.3 | 0.7 | GO:0044393 | microspike(GO:0044393) |
0.3 | 2.0 | GO:0044300 | cerebellar mossy fiber(GO:0044300) |
0.3 | 0.7 | GO:0033263 | CORVET complex(GO:0033263) |
0.3 | 6.4 | GO:0044295 | axonal growth cone(GO:0044295) |
0.3 | 0.9 | GO:0033596 | TSC1-TSC2 complex(GO:0033596) |
0.3 | 2.2 | GO:0016342 | catenin complex(GO:0016342) |
0.3 | 0.9 | GO:0000110 | nucleotide-excision repair factor 1 complex(GO:0000110) |
0.3 | 13.1 | GO:0042734 | presynaptic membrane(GO:0042734) |
0.3 | 1.2 | GO:1990716 | axonemal central apparatus(GO:1990716) |
0.3 | 2.6 | GO:0036156 | inner dynein arm(GO:0036156) |
0.3 | 1.6 | GO:0051286 | cell tip(GO:0051286) |
0.3 | 1.6 | GO:0000127 | transcription factor TFIIIC complex(GO:0000127) |
0.3 | 0.8 | GO:0009331 | glycerol-3-phosphate dehydrogenase complex(GO:0009331) |
0.2 | 1.5 | GO:0097449 | astrocyte projection(GO:0097449) |
0.2 | 1.0 | GO:0032541 | cortical endoplasmic reticulum(GO:0032541) |
0.2 | 1.2 | GO:0070695 | FHF complex(GO:0070695) |
0.2 | 2.1 | GO:0005859 | muscle myosin complex(GO:0005859) |
0.2 | 1.4 | GO:0090571 | RNA polymerase II transcription repressor complex(GO:0090571) |
0.2 | 7.1 | GO:0000307 | cyclin-dependent protein kinase holoenzyme complex(GO:0000307) |
0.2 | 0.7 | GO:0032299 | ribonuclease H2 complex(GO:0032299) |
0.2 | 0.7 | GO:0017133 | mitochondrial electron transfer flavoprotein complex(GO:0017133) electron transfer flavoprotein complex(GO:0045251) |
0.2 | 1.1 | GO:1990454 | L-type voltage-gated calcium channel complex(GO:1990454) |
0.2 | 1.1 | GO:0005683 | U7 snRNP(GO:0005683) |
0.2 | 2.5 | GO:0030123 | AP-3 adaptor complex(GO:0030123) |
0.2 | 0.6 | GO:0033269 | internode region of axon(GO:0033269) |
0.2 | 0.6 | GO:0002193 | MAML1-RBP-Jkappa- ICN1 complex(GO:0002193) |
0.2 | 1.4 | GO:0070971 | endoplasmic reticulum exit site(GO:0070971) |
0.2 | 0.8 | GO:0072588 | box H/ACA snoRNP complex(GO:0031429) box H/ACA RNP complex(GO:0072588) |
0.2 | 1.8 | GO:0043220 | Schmidt-Lanterman incisure(GO:0043220) |
0.2 | 0.2 | GO:0031523 | Myb complex(GO:0031523) |
0.2 | 1.9 | GO:0032433 | filopodium tip(GO:0032433) |
0.2 | 0.4 | GO:0070044 | synaptobrevin 2-SNAP-25-syntaxin-1a complex(GO:0070044) |
0.2 | 2.6 | GO:0000145 | exocyst(GO:0000145) |
0.2 | 0.7 | GO:0042583 | chromaffin granule(GO:0042583) |
0.2 | 0.9 | GO:0005672 | transcription factor TFIIA complex(GO:0005672) |
0.2 | 0.9 | GO:0044224 | juxtaparanode region of axon(GO:0044224) |
0.2 | 2.8 | GO:0042101 | T cell receptor complex(GO:0042101) |
0.2 | 2.1 | GO:0033655 | host cell cytoplasm(GO:0030430) host intracellular part(GO:0033646) host cell cytoplasm part(GO:0033655) intracellular region of host(GO:0043656) |
0.2 | 1.5 | GO:0000813 | ESCRT I complex(GO:0000813) |
0.2 | 0.2 | GO:0070110 | ciliary neurotrophic factor receptor complex(GO:0070110) |
0.2 | 1.2 | GO:0033180 | proton-transporting V-type ATPase, V1 domain(GO:0033180) |
0.2 | 0.3 | GO:0097441 | basilar dendrite(GO:0097441) |
0.2 | 1.8 | GO:0048786 | presynaptic active zone(GO:0048786) |
0.2 | 0.5 | GO:0042585 | germinal vesicle(GO:0042585) |
0.2 | 0.6 | GO:0044322 | endoplasmic reticulum quality control compartment(GO:0044322) |
0.1 | 2.4 | GO:0032809 | neuronal cell body membrane(GO:0032809) |
0.1 | 1.7 | GO:0098643 | fibrillar collagen trimer(GO:0005583) banded collagen fibril(GO:0098643) |
0.1 | 6.3 | GO:0005871 | kinesin complex(GO:0005871) |
0.1 | 0.3 | GO:0090576 | RNA polymerase III transcription factor complex(GO:0090576) |
0.1 | 0.9 | GO:0005577 | fibrinogen complex(GO:0005577) |
0.1 | 1.1 | GO:0005750 | mitochondrial respiratory chain complex III(GO:0005750) respiratory chain complex III(GO:0045275) |
0.1 | 0.8 | GO:0000439 | core TFIIH complex(GO:0000439) |
0.1 | 0.4 | GO:0016533 | cyclin-dependent protein kinase 5 holoenzyme complex(GO:0016533) |
0.1 | 0.3 | GO:0008282 | ATP-sensitive potassium channel complex(GO:0008282) |
0.1 | 7.7 | GO:0031463 | Cul3-RING ubiquitin ligase complex(GO:0031463) |
0.1 | 0.4 | GO:0005785 | signal recognition particle receptor complex(GO:0005785) |
0.1 | 0.1 | GO:0044299 | C-fiber(GO:0044299) |
0.1 | 0.3 | GO:0000015 | phosphopyruvate hydratase complex(GO:0000015) |
0.1 | 0.6 | GO:0031314 | extrinsic component of mitochondrial inner membrane(GO:0031314) |
0.1 | 0.9 | GO:0042575 | DNA polymerase complex(GO:0042575) |
0.1 | 0.3 | GO:0031466 | Cul5-RING ubiquitin ligase complex(GO:0031466) |
0.1 | 1.1 | GO:0031430 | M band(GO:0031430) |
0.1 | 5.7 | GO:0008076 | voltage-gated potassium channel complex(GO:0008076) |
0.1 | 1.6 | GO:0032839 | dendrite cytoplasm(GO:0032839) |
0.1 | 0.8 | GO:0001650 | fibrillar center(GO:0001650) |
0.1 | 0.4 | GO:0030127 | COPII vesicle coat(GO:0030127) |
0.1 | 0.9 | GO:0097440 | apical dendrite(GO:0097440) |
0.1 | 2.6 | GO:0005891 | voltage-gated calcium channel complex(GO:0005891) |
0.1 | 0.3 | GO:0097504 | Gemini of coiled bodies(GO:0097504) |
0.1 | 0.6 | GO:0034991 | nuclear meiotic cohesin complex(GO:0034991) |
0.1 | 2.6 | GO:0000314 | organellar small ribosomal subunit(GO:0000314) mitochondrial small ribosomal subunit(GO:0005763) |
0.1 | 0.4 | GO:0044215 | other organism(GO:0044215) other organism cell(GO:0044216) other organism part(GO:0044217) |
0.1 | 0.4 | GO:0034363 | intermediate-density lipoprotein particle(GO:0034363) |
0.1 | 0.3 | GO:0055087 | Ski complex(GO:0055087) |
0.1 | 0.3 | GO:0043625 | delta DNA polymerase complex(GO:0043625) |
0.1 | 1.6 | GO:0031233 | intrinsic component of external side of plasma membrane(GO:0031233) |
0.1 | 1.5 | GO:0005797 | Golgi medial cisterna(GO:0005797) |
0.1 | 2.0 | GO:0030672 | synaptic vesicle membrane(GO:0030672) exocytic vesicle membrane(GO:0099501) |
0.1 | 0.1 | GO:0097651 | phosphatidylinositol 3-kinase complex, class I(GO:0097651) |
0.1 | 0.3 | GO:0097470 | ribbon synapse(GO:0097470) |
0.1 | 5.5 | GO:0043204 | perikaryon(GO:0043204) |
0.1 | 0.3 | GO:0005956 | protein kinase CK2 complex(GO:0005956) |
0.1 | 1.0 | GO:0031527 | filopodium membrane(GO:0031527) |
0.1 | 0.2 | GO:0097149 | centralspindlin complex(GO:0097149) |
0.1 | 0.6 | GO:0032045 | guanyl-nucleotide exchange factor complex(GO:0032045) |
0.1 | 1.7 | GO:0034451 | centriolar satellite(GO:0034451) |
0.1 | 2.8 | GO:0005762 | organellar large ribosomal subunit(GO:0000315) mitochondrial large ribosomal subunit(GO:0005762) |
0.1 | 0.5 | GO:0034098 | VCP-NPL4-UFD1 AAA ATPase complex(GO:0034098) |
0.1 | 0.6 | GO:0036157 | outer dynein arm(GO:0036157) |
0.1 | 1.9 | GO:0046658 | anchored component of plasma membrane(GO:0046658) |
0.1 | 0.1 | GO:0030689 | Noc complex(GO:0030689) |
0.1 | 0.3 | GO:0005610 | laminin-5 complex(GO:0005610) |
0.1 | 0.2 | GO:0043511 | inhibin complex(GO:0043511) |
0.1 | 0.2 | GO:0044352 | pinosome(GO:0044352) macropinosome(GO:0044354) |
0.1 | 0.3 | GO:0005663 | DNA replication factor C complex(GO:0005663) |
0.1 | 0.2 | GO:0014731 | spectrin-associated cytoskeleton(GO:0014731) |
0.1 | 0.6 | GO:0048188 | Set1C/COMPASS complex(GO:0048188) |
0.1 | 0.9 | GO:0043205 | fibril(GO:0043205) |
0.1 | 0.8 | GO:0030914 | STAGA complex(GO:0030914) |
0.1 | 0.4 | GO:0031415 | NatA complex(GO:0031415) |
0.1 | 0.5 | GO:0031932 | TORC2 complex(GO:0031932) |
0.1 | 0.2 | GO:0042567 | insulin-like growth factor binding protein complex(GO:0016942) growth factor complex(GO:0036454) insulin-like growth factor ternary complex(GO:0042567) |
0.1 | 0.1 | GO:1990923 | PET complex(GO:1990923) |
0.1 | 0.7 | GO:0033391 | chromatoid body(GO:0033391) |
0.1 | 0.2 | GO:0000120 | RNA polymerase I transcription factor complex(GO:0000120) |
0.0 | 0.4 | GO:0030991 | intraciliary transport particle A(GO:0030991) |
0.0 | 4.8 | GO:0031225 | anchored component of membrane(GO:0031225) |
0.0 | 0.6 | GO:1902710 | GABA receptor complex(GO:1902710) GABA-A receptor complex(GO:1902711) |
0.0 | 0.3 | GO:0072557 | IPAF inflammasome complex(GO:0072557) |
0.0 | 0.8 | GO:0060170 | ciliary membrane(GO:0060170) |
0.0 | 0.7 | GO:0005605 | basal lamina(GO:0005605) |
0.0 | 0.1 | GO:0005947 | mitochondrial alpha-ketoglutarate dehydrogenase complex(GO:0005947) |
0.0 | 0.9 | GO:0005839 | proteasome core complex(GO:0005839) |
0.0 | 0.8 | GO:0032281 | AMPA glutamate receptor complex(GO:0032281) |
0.0 | 5.5 | GO:0045211 | postsynaptic membrane(GO:0045211) |
0.0 | 0.4 | GO:0030877 | beta-catenin destruction complex(GO:0030877) |
0.0 | 1.7 | GO:0005905 | clathrin-coated pit(GO:0005905) |
0.0 | 0.1 | GO:0070852 | cell body fiber(GO:0070852) |
0.0 | 0.2 | GO:0035363 | histone locus body(GO:0035363) |
0.0 | 0.6 | GO:0097546 | ciliary base(GO:0097546) |
0.0 | 0.9 | GO:0030687 | preribosome, large subunit precursor(GO:0030687) |
0.0 | 0.6 | GO:0005666 | DNA-directed RNA polymerase III complex(GO:0005666) |
0.0 | 0.1 | GO:0044447 | axoneme part(GO:0044447) |
0.0 | 0.2 | GO:0001652 | granular component(GO:0001652) |
0.0 | 0.1 | GO:0097209 | epidermal lamellar body(GO:0097209) |
0.0 | 0.1 | GO:1990357 | terminal web(GO:1990357) |
0.0 | 0.5 | GO:0097228 | sperm principal piece(GO:0097228) |
0.0 | 0.0 | GO:0071598 | neuronal ribonucleoprotein granule(GO:0071598) |
0.0 | 0.1 | GO:0000322 | storage vacuole(GO:0000322) |
0.0 | 0.3 | GO:0045277 | respiratory chain complex IV(GO:0045277) |
0.0 | 0.1 | GO:0071797 | LUBAC complex(GO:0071797) |
0.0 | 0.2 | GO:0000796 | condensin complex(GO:0000796) |
0.0 | 0.0 | GO:0031258 | lamellipodium membrane(GO:0031258) |
0.0 | 0.3 | GO:0005885 | Arp2/3 protein complex(GO:0005885) |
0.0 | 0.1 | GO:0001674 | female germ cell nucleus(GO:0001674) |
0.0 | 0.1 | GO:1990393 | 3M complex(GO:1990393) |
0.0 | 0.1 | GO:0097136 | Bcl-2 family protein complex(GO:0097136) |
0.0 | 0.1 | GO:1990131 | EGO complex(GO:0034448) Gtr1-Gtr2 GTPase complex(GO:1990131) |
0.0 | 0.1 | GO:0045098 | type III intermediate filament(GO:0045098) |
0.0 | 0.1 | GO:0098644 | complex of collagen trimers(GO:0098644) |
0.0 | 0.1 | GO:0030314 | junctional membrane complex(GO:0030314) |
0.0 | 0.1 | GO:0034365 | discoidal high-density lipoprotein particle(GO:0034365) |
0.0 | 0.5 | GO:0031306 | intrinsic component of mitochondrial outer membrane(GO:0031306) |
0.0 | 0.0 | GO:0031467 | Cul7-RING ubiquitin ligase complex(GO:0031467) |
0.0 | 0.6 | GO:0030315 | T-tubule(GO:0030315) |
0.0 | 0.2 | GO:0031595 | nuclear proteasome complex(GO:0031595) |
0.0 | 0.5 | GO:0032391 | photoreceptor connecting cilium(GO:0032391) |
0.0 | 0.4 | GO:0042588 | zymogen granule(GO:0042588) |
0.0 | 0.1 | GO:0030896 | checkpoint clamp complex(GO:0030896) |
0.0 | 0.1 | GO:0005736 | DNA-directed RNA polymerase I complex(GO:0005736) |
0.0 | 0.4 | GO:0005922 | connexon complex(GO:0005922) |
0.0 | 0.1 | GO:0033256 | I-kappaB/NF-kappaB complex(GO:0033256) |
0.0 | 0.2 | GO:0035631 | CD40 receptor complex(GO:0035631) |
0.0 | 0.0 | GO:0033268 | node of Ranvier(GO:0033268) |
0.0 | 0.1 | GO:0032585 | multivesicular body membrane(GO:0032585) |
0.0 | 0.0 | GO:0097025 | MPP7-DLG1-LIN7 complex(GO:0097025) |
0.0 | 0.2 | GO:0071006 | U2-type catalytic step 1 spliceosome(GO:0071006) |
0.0 | 0.0 | GO:0044308 | axonal spine(GO:0044308) |
0.0 | 0.0 | GO:0071008 | U2-type post-mRNA release spliceosomal complex(GO:0071008) |
0.0 | 0.1 | GO:0002177 | manchette(GO:0002177) |
0.0 | 0.0 | GO:0032009 | early phagosome(GO:0032009) |
0.0 | 0.1 | GO:0005869 | dynactin complex(GO:0005869) |
0.0 | 0.0 | GO:0070033 | synaptobrevin 2-SNAP-25-syntaxin-1a-complexin II complex(GO:0070033) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
8.3 | 24.9 | GO:0005519 | cytoskeletal regulatory protein binding(GO:0005519) |
2.5 | 12.3 | GO:0044323 | retinoic acid-responsive element binding(GO:0044323) |
2.3 | 6.8 | GO:0070699 | type II activin receptor binding(GO:0070699) |
2.1 | 6.3 | GO:0030158 | protein xylosyltransferase activity(GO:0030158) |
1.8 | 16.2 | GO:0001091 | RNA polymerase II basal transcription factor binding(GO:0001091) |
1.8 | 5.3 | GO:0097109 | neuroligin family protein binding(GO:0097109) |
1.6 | 4.9 | GO:0005001 | transmembrane receptor protein tyrosine phosphatase activity(GO:0005001) |
1.6 | 4.8 | GO:0015142 | citrate transmembrane transporter activity(GO:0015137) tricarboxylic acid transmembrane transporter activity(GO:0015142) |
1.5 | 4.4 | GO:0004980 | melanocyte-stimulating hormone receptor activity(GO:0004980) |
1.4 | 2.8 | GO:0004886 | 9-cis retinoic acid receptor activity(GO:0004886) |
1.2 | 8.5 | GO:0005004 | GPI-linked ephrin receptor activity(GO:0005004) |
1.1 | 3.4 | GO:0005176 | ErbB-2 class receptor binding(GO:0005176) |
1.1 | 4.4 | GO:0015272 | ATP-activated inward rectifier potassium channel activity(GO:0015272) |
1.1 | 4.3 | GO:0016715 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced ascorbate as one donor, and incorporation of one atom of oxygen(GO:0016715) |
0.9 | 2.8 | GO:0097108 | hedgehog family protein binding(GO:0097108) |
0.9 | 11.8 | GO:0008574 | ATP-dependent microtubule motor activity, plus-end-directed(GO:0008574) |
0.9 | 4.4 | GO:0003828 | alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity(GO:0003828) |
0.8 | 3.4 | GO:0035727 | lysophosphatidic acid binding(GO:0035727) |
0.8 | 7.5 | GO:0001206 | transcriptional repressor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001206) |
0.8 | 3.1 | GO:0031694 | alpha-2A adrenergic receptor binding(GO:0031694) |
0.7 | 4.2 | GO:0004716 | receptor signaling protein tyrosine kinase activity(GO:0004716) |
0.7 | 2.1 | GO:0004351 | glutamate decarboxylase activity(GO:0004351) |
0.7 | 10.0 | GO:0031402 | sodium ion binding(GO:0031402) |
0.7 | 2.0 | GO:0043423 | 3-phosphoinositide-dependent protein kinase binding(GO:0043423) |
0.6 | 4.4 | GO:0103116 | alpha-D-galactofuranose transporter activity(GO:0103116) |
0.6 | 1.9 | GO:0004471 | malic enzyme activity(GO:0004470) malate dehydrogenase (decarboxylating) (NAD+) activity(GO:0004471) |
0.6 | 7.6 | GO:0015172 | acidic amino acid transmembrane transporter activity(GO:0015172) |
0.6 | 2.5 | GO:0070878 | primary miRNA binding(GO:0070878) |
0.6 | 1.2 | GO:0045503 | dynein light chain binding(GO:0045503) |
0.6 | 3.6 | GO:0043140 | ATP-dependent 3'-5' DNA helicase activity(GO:0043140) |
0.6 | 3.0 | GO:0001025 | RNA polymerase III transcription factor binding(GO:0001025) |
0.6 | 4.8 | GO:0016861 | intramolecular oxidoreductase activity, interconverting aldoses and ketoses(GO:0016861) |
0.6 | 11.7 | GO:0017075 | syntaxin-1 binding(GO:0017075) |
0.6 | 5.2 | GO:0038191 | neuropilin binding(GO:0038191) |
0.6 | 1.7 | GO:0004829 | threonine-tRNA ligase activity(GO:0004829) |
0.6 | 1.2 | GO:0000099 | sulfur amino acid transmembrane transporter activity(GO:0000099) |
0.6 | 1.7 | GO:0019153 | protein-disulfide reductase (glutathione) activity(GO:0019153) |
0.6 | 2.2 | GO:0043262 | adenosine-diphosphatase activity(GO:0043262) |
0.5 | 8.7 | GO:0017128 | phospholipid scramblase activity(GO:0017128) |
0.5 | 3.7 | GO:0046790 | virion binding(GO:0046790) |
0.5 | 1.1 | GO:0035373 | chondroitin sulfate proteoglycan binding(GO:0035373) |
0.5 | 1.6 | GO:0016015 | morphogen activity(GO:0016015) |
0.5 | 2.5 | GO:0030553 | cGMP binding(GO:0030553) |
0.5 | 2.4 | GO:0086006 | voltage-gated sodium channel activity involved in cardiac muscle cell action potential(GO:0086006) |
0.5 | 3.9 | GO:0005167 | neurotrophin TRK receptor binding(GO:0005167) |
0.5 | 2.9 | GO:0004311 | farnesyltranstransferase activity(GO:0004311) |
0.5 | 1.9 | GO:0004060 | arylamine N-acetyltransferase activity(GO:0004060) |
0.5 | 1.4 | GO:0048101 | calcium- and calmodulin-regulated 3',5'-cyclic-GMP phosphodiesterase activity(GO:0048101) |
0.5 | 2.3 | GO:0015185 | gamma-aminobutyric acid transmembrane transporter activity(GO:0015185) |
0.5 | 5.6 | GO:0031005 | filamin binding(GO:0031005) |
0.5 | 2.8 | GO:0048495 | Roundabout binding(GO:0048495) |
0.4 | 2.2 | GO:0086080 | protein binding involved in heterotypic cell-cell adhesion(GO:0086080) |
0.4 | 2.6 | GO:0032027 | myosin light chain binding(GO:0032027) |
0.4 | 2.6 | GO:0008517 | folic acid transporter activity(GO:0008517) |
0.4 | 3.0 | GO:0005223 | intracellular cGMP activated cation channel activity(GO:0005223) |
0.4 | 1.6 | GO:0015467 | G-protein activated inward rectifier potassium channel activity(GO:0015467) |
0.4 | 4.8 | GO:0030215 | semaphorin receptor binding(GO:0030215) |
0.4 | 0.4 | GO:0050816 | phosphothreonine binding(GO:0050816) |
0.4 | 1.1 | GO:0015277 | kainate selective glutamate receptor activity(GO:0015277) |
0.4 | 1.5 | GO:0070567 | cytidylyltransferase activity(GO:0070567) |
0.4 | 1.1 | GO:0043546 | molybdopterin cofactor binding(GO:0043546) |
0.4 | 1.5 | GO:0004749 | ribose phosphate diphosphokinase activity(GO:0004749) |
0.4 | 4.8 | GO:0000983 | transcription factor activity, RNA polymerase II core promoter sequence-specific(GO:0000983) |
0.4 | 1.8 | GO:0005283 | sodium:amino acid symporter activity(GO:0005283) |
0.4 | 1.5 | GO:0030911 | TPR domain binding(GO:0030911) |
0.4 | 0.7 | GO:0005030 | neurotrophin receptor activity(GO:0005030) |
0.4 | 7.5 | GO:0004120 | calmodulin-dependent cyclic-nucleotide phosphodiesterase activity(GO:0004117) cGMP-stimulated cyclic-nucleotide phosphodiesterase activity(GO:0004118) cGMP-inhibited cyclic-nucleotide phosphodiesterase activity(GO:0004119) photoreceptor cyclic-nucleotide phosphodiesterase activity(GO:0004120) 7,8-dihydro-D-neopterin 2',3'-cyclic phosphate phosphodiesterase activity(GO:0044688) inositol phosphosphingolipid phospholipase activity(GO:0052712) inositol phosphorylceramide phospholipase activity(GO:0052713) mannosyl-inositol phosphorylceramide phospholipase activity(GO:0052714) mannosyl-diinositol phosphorylceramide phospholipase activity(GO:0052715) |
0.4 | 8.2 | GO:0004181 | metallocarboxypeptidase activity(GO:0004181) |
0.4 | 1.1 | GO:0051880 | G-quadruplex DNA binding(GO:0051880) |
0.4 | 1.1 | GO:0019166 | trans-2-enoyl-CoA reductase (NADPH) activity(GO:0019166) |
0.4 | 0.7 | GO:0015222 | serotonin transmembrane transporter activity(GO:0015222) |
0.3 | 5.1 | GO:0016805 | dipeptidase activity(GO:0016805) |
0.3 | 2.0 | GO:0032184 | SUMO polymer binding(GO:0032184) |
0.3 | 1.3 | GO:0005042 | netrin receptor activity(GO:0005042) |
0.3 | 0.9 | GO:0030955 | potassium ion binding(GO:0030955) |
0.3 | 4.3 | GO:0045295 | gamma-catenin binding(GO:0045295) |
0.3 | 1.2 | GO:0005250 | A-type (transient outward) potassium channel activity(GO:0005250) |
0.3 | 5.4 | GO:0080025 | phosphatidylinositol-3,5-bisphosphate binding(GO:0080025) |
0.3 | 6.3 | GO:0030332 | cyclin binding(GO:0030332) |
0.3 | 1.5 | GO:0008499 | UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase activity(GO:0008499) |
0.3 | 0.9 | GO:0071209 | U7 snRNA binding(GO:0071209) |
0.3 | 4.7 | GO:0015269 | calcium-activated potassium channel activity(GO:0015269) |
0.3 | 2.5 | GO:0008093 | cytoskeletal adaptor activity(GO:0008093) |
0.3 | 0.8 | GO:0035514 | DNA demethylase activity(GO:0035514) |
0.3 | 1.1 | GO:0097001 | ceramide binding(GO:0097001) |
0.3 | 2.7 | GO:0042043 | neurexin family protein binding(GO:0042043) |
0.3 | 0.8 | GO:0016520 | growth hormone-releasing hormone receptor activity(GO:0016520) |
0.3 | 1.6 | GO:0015180 | L-alanine transmembrane transporter activity(GO:0015180) alanine transmembrane transporter activity(GO:0022858) |
0.3 | 0.8 | GO:0042392 | sphingosine-1-phosphate phosphatase activity(GO:0042392) |
0.3 | 0.8 | GO:0004367 | glycerol-3-phosphate dehydrogenase [NAD+] activity(GO:0004367) |
0.3 | 2.0 | GO:0005068 | transmembrane receptor protein tyrosine kinase adaptor activity(GO:0005068) |
0.3 | 0.3 | GO:0031852 | mu-type opioid receptor binding(GO:0031852) |
0.3 | 1.0 | GO:0016018 | cyclosporin A binding(GO:0016018) |
0.2 | 0.5 | GO:0098632 | protein binding involved in cell-cell adhesion(GO:0098632) |
0.2 | 1.5 | GO:0047498 | calcium-dependent phospholipase A2 activity(GO:0047498) |
0.2 | 1.7 | GO:0001640 | adenylate cyclase inhibiting G-protein coupled glutamate receptor activity(GO:0001640) |
0.2 | 1.7 | GO:0008494 | translation activator activity(GO:0008494) |
0.2 | 0.2 | GO:0071208 | histone pre-mRNA DCP binding(GO:0071208) |
0.2 | 0.7 | GO:0008332 | low voltage-gated calcium channel activity(GO:0008332) |
0.2 | 0.9 | GO:0046923 | ER retention sequence binding(GO:0046923) |
0.2 | 0.9 | GO:0004065 | arylsulfatase activity(GO:0004065) |
0.2 | 1.1 | GO:0004176 | ATP-dependent peptidase activity(GO:0004176) |
0.2 | 2.0 | GO:0001162 | RNA polymerase II intronic transcription regulatory region sequence-specific DNA binding(GO:0001162) |
0.2 | 0.9 | GO:0046935 | 1-phosphatidylinositol-3-kinase regulator activity(GO:0046935) |
0.2 | 0.7 | GO:0004667 | prostaglandin-D synthase activity(GO:0004667) |
0.2 | 0.9 | GO:0004971 | AMPA glutamate receptor activity(GO:0004971) |
0.2 | 0.7 | GO:0033829 | O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase activity(GO:0033829) |
0.2 | 0.6 | GO:0042609 | CD4 receptor binding(GO:0042609) |
0.2 | 1.1 | GO:0001515 | opioid peptide activity(GO:0001515) |
0.2 | 2.3 | GO:0008331 | high voltage-gated calcium channel activity(GO:0008331) |
0.2 | 0.6 | GO:0051425 | PTB domain binding(GO:0051425) |
0.2 | 2.1 | GO:0017147 | Wnt-protein binding(GO:0017147) |
0.2 | 1.9 | GO:0008545 | JUN kinase kinase activity(GO:0008545) |
0.2 | 0.9 | GO:0004565 | beta-galactosidase activity(GO:0004565) |
0.2 | 2.4 | GO:0015026 | coreceptor activity(GO:0015026) |
0.2 | 0.5 | GO:0016649 | electron-transferring-flavoprotein dehydrogenase activity(GO:0004174) oxidoreductase activity, acting on the CH-NH group of donors, quinone or similar compound as acceptor(GO:0016649) |
0.2 | 0.2 | GO:0033142 | progesterone receptor binding(GO:0033142) |
0.2 | 1.8 | GO:0034236 | protein kinase A catalytic subunit binding(GO:0034236) |
0.2 | 0.4 | GO:0000405 | bubble DNA binding(GO:0000405) |
0.2 | 0.4 | GO:0042285 | UDP-xylosyltransferase activity(GO:0035252) xylosyltransferase activity(GO:0042285) |
0.2 | 0.9 | GO:0004523 | RNA-DNA hybrid ribonuclease activity(GO:0004523) |
0.2 | 0.5 | GO:0004605 | phosphatidate cytidylyltransferase activity(GO:0004605) |
0.2 | 5.6 | GO:0070888 | E-box binding(GO:0070888) |
0.2 | 0.5 | GO:0031800 | type 3 metabotropic glutamate receptor binding(GO:0031800) |
0.2 | 0.3 | GO:0009374 | biotin binding(GO:0009374) |
0.2 | 0.2 | GO:0030284 | estrogen receptor activity(GO:0030284) |
0.2 | 0.5 | GO:0003829 | beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase activity(GO:0003829) |
0.2 | 1.7 | GO:0004983 | neuropeptide Y receptor activity(GO:0004983) |
0.2 | 1.0 | GO:0031419 | cobalamin binding(GO:0031419) |
0.2 | 7.7 | GO:0034483 | heparan sulfate sulfotransferase activity(GO:0034483) |
0.2 | 0.3 | GO:0030620 | U2 snRNA binding(GO:0030620) |
0.2 | 0.6 | GO:0031433 | telethonin binding(GO:0031433) |
0.2 | 0.8 | GO:0005007 | fibroblast growth factor-activated receptor activity(GO:0005007) |
0.2 | 0.6 | GO:0034714 | type III transforming growth factor beta receptor binding(GO:0034714) |
0.2 | 0.3 | GO:0031893 | vasopressin receptor binding(GO:0031893) |
0.2 | 0.6 | GO:0004459 | L-lactate dehydrogenase activity(GO:0004459) |
0.2 | 0.5 | GO:0004720 | protein-lysine 6-oxidase activity(GO:0004720) |
0.1 | 0.6 | GO:0008502 | melatonin receptor activity(GO:0008502) |
0.1 | 0.6 | GO:0034596 | phosphatidylinositol phosphate 4-phosphatase activity(GO:0034596) |
0.1 | 1.2 | GO:0008599 | protein phosphatase type 1 regulator activity(GO:0008599) |
0.1 | 1.5 | GO:0070180 | large ribosomal subunit rRNA binding(GO:0070180) |
0.1 | 0.9 | GO:0003910 | DNA ligase activity(GO:0003909) DNA ligase (ATP) activity(GO:0003910) |
0.1 | 0.6 | GO:0004985 | opioid receptor activity(GO:0004985) |
0.1 | 0.6 | GO:0070569 | uridylyltransferase activity(GO:0070569) |
0.1 | 0.4 | GO:0030375 | thyroid hormone receptor coactivator activity(GO:0030375) |
0.1 | 1.7 | GO:0051018 | protein kinase A binding(GO:0051018) |
0.1 | 0.6 | GO:0004792 | thiosulfate sulfurtransferase activity(GO:0004792) |
0.1 | 2.2 | GO:0034237 | protein kinase A regulatory subunit binding(GO:0034237) |
0.1 | 3.5 | GO:0030507 | spectrin binding(GO:0030507) |
0.1 | 3.7 | GO:0015347 | sodium-independent organic anion transmembrane transporter activity(GO:0015347) |
0.1 | 0.4 | GO:0016802 | adenosylhomocysteinase activity(GO:0004013) trialkylsulfonium hydrolase activity(GO:0016802) |
0.1 | 1.5 | GO:0001671 | ATPase activator activity(GO:0001671) |
0.1 | 1.6 | GO:1990841 | promoter-specific chromatin binding(GO:1990841) |
0.1 | 0.5 | GO:0031727 | CCR2 chemokine receptor binding(GO:0031727) |
0.1 | 0.8 | GO:0035473 | lipase binding(GO:0035473) |
0.1 | 1.4 | GO:0036218 | thiamine-pyrophosphatase activity(GO:0004787) UDP-2,3-diacylglucosamine hydrolase activity(GO:0008758) dATP pyrophosphohydrolase activity(GO:0008828) dihydroneopterin monophosphate phosphatase activity(GO:0019176) dihydroneopterin triphosphate pyrophosphohydrolase activity(GO:0019177) dTTP diphosphatase activity(GO:0036218) phosphocholine hydrolase activity(GO:0044606) |
0.1 | 0.9 | GO:1990247 | N6-methyladenosine-containing RNA binding(GO:1990247) |
0.1 | 0.5 | GO:0004035 | alkaline phosphatase activity(GO:0004035) |
0.1 | 8.7 | GO:0005089 | Rho guanyl-nucleotide exchange factor activity(GO:0005089) |
0.1 | 0.6 | GO:0019784 | NEDD8-specific protease activity(GO:0019784) |
0.1 | 0.4 | GO:0005483 | soluble NSF attachment protein activity(GO:0005483) |
0.1 | 1.5 | GO:0048407 | platelet-derived growth factor binding(GO:0048407) |
0.1 | 0.7 | GO:0046974 | histone methyltransferase activity (H3-K9 specific)(GO:0046974) |
0.1 | 0.4 | GO:0035529 | NADH pyrophosphatase activity(GO:0035529) |
0.1 | 0.9 | GO:0003896 | DNA primase activity(GO:0003896) |
0.1 | 0.2 | GO:0048763 | calcium-induced calcium release activity(GO:0048763) |
0.1 | 3.1 | GO:0005184 | neuropeptide hormone activity(GO:0005184) |
0.1 | 0.5 | GO:0004897 | ciliary neurotrophic factor receptor activity(GO:0004897) |
0.1 | 2.3 | GO:0042813 | Wnt-activated receptor activity(GO:0042813) |
0.1 | 0.7 | GO:0001588 | dopamine neurotransmitter receptor activity, coupled via Gs(GO:0001588) |
0.1 | 0.1 | GO:0035650 | AP-1 adaptor complex binding(GO:0035650) |
0.1 | 1.9 | GO:0030742 | GTP-dependent protein binding(GO:0030742) |
0.1 | 0.5 | GO:0004969 | histamine receptor activity(GO:0004969) |
0.1 | 2.3 | GO:0008139 | nuclear localization sequence binding(GO:0008139) |
0.1 | 0.8 | GO:0050998 | nitric-oxide synthase binding(GO:0050998) |
0.1 | 0.4 | GO:0043184 | vascular endothelial growth factor receptor 2 binding(GO:0043184) |
0.1 | 0.2 | GO:0004706 | JUN kinase kinase kinase activity(GO:0004706) |
0.1 | 0.2 | GO:0030297 | transmembrane receptor protein tyrosine kinase activator activity(GO:0030297) |
0.1 | 1.5 | GO:0099589 | G-protein coupled serotonin receptor activity(GO:0004993) serotonin receptor activity(GO:0099589) |
0.1 | 0.5 | GO:0003958 | NADPH-hemoprotein reductase activity(GO:0003958) |
0.1 | 2.3 | GO:0043014 | alpha-tubulin binding(GO:0043014) |
0.1 | 4.4 | GO:0017022 | myosin binding(GO:0017022) |
0.1 | 2.1 | GO:0005537 | mannose binding(GO:0005537) |
0.1 | 0.5 | GO:0035671 | enone reductase activity(GO:0035671) |
0.1 | 3.0 | GO:0005164 | tumor necrosis factor receptor binding(GO:0005164) |
0.1 | 2.2 | GO:0019206 | nucleoside kinase activity(GO:0019206) |
0.1 | 1.1 | GO:0004000 | adenosine deaminase activity(GO:0004000) |
0.1 | 0.5 | GO:0004826 | phenylalanine-tRNA ligase activity(GO:0004826) |
0.1 | 0.4 | GO:0034056 | estrogen response element binding(GO:0034056) |
0.1 | 0.4 | GO:0030274 | LIM domain binding(GO:0030274) |
0.1 | 0.1 | GO:0008309 | double-stranded DNA exodeoxyribonuclease activity(GO:0008309) |
0.1 | 0.7 | GO:0097027 | ubiquitin-protein transferase activator activity(GO:0097027) |
0.1 | 0.2 | GO:0004127 | cytidylate kinase activity(GO:0004127) |
0.1 | 0.5 | GO:0016937 | short-branched-chain-acyl-CoA dehydrogenase activity(GO:0016937) |
0.1 | 0.3 | GO:0004346 | glucose-6-phosphatase activity(GO:0004346) sugar-terminal-phosphatase activity(GO:0050309) |
0.1 | 0.2 | GO:0005006 | epidermal growth factor-activated receptor activity(GO:0005006) |
0.1 | 0.3 | GO:0019808 | polyamine binding(GO:0019808) |
0.1 | 1.2 | GO:0016493 | C-C chemokine receptor activity(GO:0016493) |
0.1 | 0.7 | GO:0005452 | inorganic anion exchanger activity(GO:0005452) |
0.1 | 0.2 | GO:0050510 | N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase activity(GO:0050510) |
0.1 | 0.3 | GO:0071532 | ankyrin repeat binding(GO:0071532) |
0.1 | 0.4 | GO:0004994 | somatostatin receptor activity(GO:0004994) |
0.1 | 0.8 | GO:0030159 | receptor signaling complex scaffold activity(GO:0030159) |
0.1 | 0.5 | GO:0005229 | intracellular calcium activated chloride channel activity(GO:0005229) |
0.1 | 0.2 | GO:0016901 | oxidoreductase activity, acting on the CH-OH group of donors, quinone or similar compound as acceptor(GO:0016901) |
0.1 | 0.1 | GO:0060228 | phosphatidylcholine-sterol O-acyltransferase activator activity(GO:0060228) |
0.1 | 1.0 | GO:0070064 | proline-rich region binding(GO:0070064) |
0.1 | 0.3 | GO:0031493 | nucleosomal histone binding(GO:0031493) |
0.1 | 0.2 | GO:0005275 | amine transmembrane transporter activity(GO:0005275) |
0.1 | 0.2 | GO:0008503 | benzodiazepine receptor activity(GO:0008503) |
0.1 | 0.8 | GO:0050811 | GABA receptor binding(GO:0050811) |
0.1 | 0.8 | GO:0016713 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced iron-sulfur protein as one donor, and incorporation of one atom of oxygen(GO:0016713) |
0.1 | 2.1 | GO:0005484 | SNAP receptor activity(GO:0005484) |
0.1 | 0.2 | GO:0034191 | apolipoprotein A-I receptor binding(GO:0034191) |
0.1 | 0.2 | GO:0005148 | prolactin receptor binding(GO:0005148) |
0.1 | 0.3 | GO:0071074 | eukaryotic initiation factor eIF2 binding(GO:0071074) |
0.1 | 0.4 | GO:1904264 | ubiquitin protein ligase activity involved in ERAD pathway(GO:1904264) |
0.1 | 1.3 | GO:0017134 | fibroblast growth factor binding(GO:0017134) |
0.1 | 0.3 | GO:0043855 | intracellular cyclic nucleotide activated cation channel activity(GO:0005221) cyclic nucleotide-gated ion channel activity(GO:0043855) |
0.1 | 0.1 | GO:0004952 | dopamine neurotransmitter receptor activity, coupled via Gi/Go(GO:0001591) dopamine neurotransmitter receptor activity(GO:0004952) |
0.1 | 1.0 | GO:0046966 | thyroid hormone receptor binding(GO:0046966) |
0.1 | 0.3 | GO:0046975 | histone methyltransferase activity (H3-K36 specific)(GO:0046975) |
0.1 | 0.2 | GO:0016822 | hydrolase activity, acting on acid carbon-carbon bonds(GO:0016822) hydrolase activity, acting on acid carbon-carbon bonds, in ketonic substances(GO:0016823) |
0.1 | 0.6 | GO:0070679 | inositol 1,4,5 trisphosphate binding(GO:0070679) |
0.1 | 0.2 | GO:0008184 | glycogen phosphorylase activity(GO:0008184) |
0.1 | 0.1 | GO:0004528 | phosphodiesterase I activity(GO:0004528) |
0.1 | 0.9 | GO:0070325 | lipoprotein particle receptor binding(GO:0070325) |
0.1 | 0.7 | GO:0005234 | extracellular-glutamate-gated ion channel activity(GO:0005234) |
0.1 | 0.1 | GO:0098988 | G-protein coupled glutamate receptor activity(GO:0098988) |
0.1 | 2.5 | GO:0031593 | polyubiquitin binding(GO:0031593) |
0.1 | 0.3 | GO:0099528 | G-protein coupled neurotransmitter receptor activity(GO:0099528) |
0.1 | 0.6 | GO:0004596 | peptide alpha-N-acetyltransferase activity(GO:0004596) |
0.1 | 0.2 | GO:0008532 | N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity(GO:0008532) |
0.1 | 0.2 | GO:0001161 | intronic transcription regulatory region sequence-specific DNA binding(GO:0001161) |
0.1 | 0.6 | GO:0042923 | neuropeptide binding(GO:0042923) |
0.1 | 0.4 | GO:0004571 | mannosyl-oligosaccharide 1,2-alpha-mannosidase activity(GO:0004571) |
0.1 | 0.6 | GO:0070636 | single-strand selective uracil DNA N-glycosylase activity(GO:0017065) nicotinamide riboside hydrolase activity(GO:0070635) nicotinic acid riboside hydrolase activity(GO:0070636) deoxyribonucleoside 5'-monophosphate N-glycosidase activity(GO:0070694) |
0.1 | 0.1 | GO:0043533 | inositol 1,3,4,5 tetrakisphosphate binding(GO:0043533) |
0.1 | 0.1 | GO:0097603 | temperature-gated ion channel activity(GO:0097603) |
0.1 | 0.3 | GO:0004758 | serine C-palmitoyltransferase activity(GO:0004758) |
0.1 | 0.1 | GO:0051765 | inositol tetrakisphosphate kinase activity(GO:0051765) |
0.1 | 0.4 | GO:0001135 | transcription factor activity, RNA polymerase II transcription factor recruiting(GO:0001135) |
0.1 | 0.3 | GO:0000155 | phosphorelay sensor kinase activity(GO:0000155) |
0.1 | 0.2 | GO:0016262 | protein N-acetylglucosaminyltransferase activity(GO:0016262) |
0.1 | 0.2 | GO:0071723 | lipopeptide binding(GO:0071723) |
0.1 | 0.9 | GO:0005086 | ARF guanyl-nucleotide exchange factor activity(GO:0005086) |
0.1 | 0.1 | GO:0008381 | mechanically-gated ion channel activity(GO:0008381) mechanically gated channel activity(GO:0022833) |
0.0 | 0.2 | GO:0102344 | 3-hydroxy-behenoyl-CoA dehydratase activity(GO:0102344) 3-hydroxy-lignoceroyl-CoA dehydratase activity(GO:0102345) |
0.0 | 0.1 | GO:0030899 | calcium-dependent ATPase activity(GO:0030899) |
0.0 | 0.2 | GO:0000293 | ferric-chelate reductase activity(GO:0000293) |
0.0 | 0.3 | GO:0015271 | outward rectifier potassium channel activity(GO:0015271) |
0.0 | 0.1 | GO:0004103 | choline kinase activity(GO:0004103) |
0.0 | 0.0 | GO:0035851 | Krueppel-associated box domain binding(GO:0035851) |
0.0 | 0.7 | GO:0015035 | protein disulfide oxidoreductase activity(GO:0015035) |
0.0 | 0.5 | GO:0022842 | leak channel activity(GO:0022840) narrow pore channel activity(GO:0022842) |
0.0 | 0.2 | GO:0045340 | mercury ion binding(GO:0045340) |
0.0 | 0.2 | GO:0004767 | sphingomyelin phosphodiesterase activity(GO:0004767) |
0.0 | 0.7 | GO:0071855 | neuropeptide receptor binding(GO:0071855) |
0.0 | 0.7 | GO:0016755 | transferase activity, transferring amino-acyl groups(GO:0016755) |
0.0 | 0.5 | GO:0004435 | phosphatidylinositol phospholipase C activity(GO:0004435) |
0.0 | 0.2 | GO:0034618 | arginine binding(GO:0034618) |
0.0 | 0.0 | GO:1902282 | voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization(GO:1902282) |
0.0 | 0.7 | GO:0005272 | sodium channel activity(GO:0005272) |
0.0 | 0.1 | GO:0032356 | oxidized DNA binding(GO:0032356) oxidized purine DNA binding(GO:0032357) |
0.0 | 0.1 | GO:0008525 | phosphatidylcholine transporter activity(GO:0008525) |
0.0 | 0.1 | GO:0004938 | alpha2-adrenergic receptor activity(GO:0004938) |
0.0 | 0.4 | GO:0015129 | lactate transmembrane transporter activity(GO:0015129) |
0.0 | 0.9 | GO:0017080 | sodium channel regulator activity(GO:0017080) |
0.0 | 0.6 | GO:0001056 | RNA polymerase III activity(GO:0001056) |
0.0 | 0.4 | GO:0035198 | miRNA binding(GO:0035198) |
0.0 | 0.2 | GO:0052723 | inositol hexakisphosphate kinase activity(GO:0000828) inositol hexakisphosphate 5-kinase activity(GO:0000832) inositol hexakisphosphate 1-kinase activity(GO:0052723) inositol hexakisphosphate 3-kinase activity(GO:0052724) |
0.0 | 0.1 | GO:0033592 | RNA strand annealing activity(GO:0033592) |
0.0 | 1.8 | GO:0016765 | transferase activity, transferring alkyl or aryl (other than methyl) groups(GO:0016765) |
0.0 | 0.5 | GO:0004890 | GABA-A receptor activity(GO:0004890) |
0.0 | 0.1 | GO:0051185 | coenzyme transporter activity(GO:0051185) |
0.0 | 0.1 | GO:0005346 | adenine nucleotide transmembrane transporter activity(GO:0000295) purine ribonucleotide transmembrane transporter activity(GO:0005346) purine nucleotide transmembrane transporter activity(GO:0015216) |
0.0 | 0.1 | GO:0004703 | G-protein coupled receptor kinase activity(GO:0004703) |
0.0 | 0.3 | GO:0005522 | profilin binding(GO:0005522) |
0.0 | 0.6 | GO:0005186 | pheromone activity(GO:0005186) |
0.0 | 0.3 | GO:0015928 | fucosidase activity(GO:0015928) |
0.0 | 0.7 | GO:0008330 | protein tyrosine/threonine phosphatase activity(GO:0008330) |
0.0 | 0.0 | GO:0017099 | very-long-chain-acyl-CoA dehydrogenase activity(GO:0017099) |
0.0 | 0.2 | GO:0015194 | L-serine transmembrane transporter activity(GO:0015194) serine transmembrane transporter activity(GO:0022889) |
0.0 | 0.2 | GO:0070411 | I-SMAD binding(GO:0070411) |
0.0 | 0.2 | GO:0008296 | 3'-5'-exodeoxyribonuclease activity(GO:0008296) |
0.0 | 0.2 | GO:0061133 | endopeptidase activator activity(GO:0061133) |
0.0 | 0.1 | GO:0004937 | alpha1-adrenergic receptor activity(GO:0004937) |
0.0 | 0.1 | GO:1990381 | ubiquitin-specific protease binding(GO:1990381) |
0.0 | 0.0 | GO:0004967 | glucagon receptor activity(GO:0004967) |
0.0 | 0.0 | GO:0032142 | single guanine insertion binding(GO:0032142) |
0.0 | 0.1 | GO:0004995 | tachykinin receptor activity(GO:0004995) |
0.0 | 0.2 | GO:0004534 | 5'-3' exoribonuclease activity(GO:0004534) |
0.0 | 0.6 | GO:0005245 | voltage-gated calcium channel activity(GO:0005245) |
0.0 | 0.1 | GO:0008475 | procollagen-lysine 5-dioxygenase activity(GO:0008475) |
0.0 | 0.1 | GO:0004920 | interleukin-10 receptor activity(GO:0004920) |
0.0 | 0.0 | GO:0070915 | lysophosphatidic acid receptor activity(GO:0070915) |
0.0 | 1.2 | GO:0005267 | potassium channel activity(GO:0005267) |
0.0 | 0.1 | GO:0035663 | Toll-like receptor 2 binding(GO:0035663) |
0.0 | 0.1 | GO:0001054 | RNA polymerase I activity(GO:0001054) |
0.0 | 0.1 | GO:0055106 | ligase regulator activity(GO:0055103) ubiquitin-protein transferase regulator activity(GO:0055106) |
0.0 | 0.5 | GO:0001106 | RNA polymerase II transcription corepressor activity(GO:0001106) |
0.0 | 0.8 | GO:0017046 | peptide hormone binding(GO:0017046) |
0.0 | 0.1 | GO:0030296 | protein tyrosine kinase activator activity(GO:0030296) |
0.0 | 0.1 | GO:0055100 | adiponectin binding(GO:0055100) |
0.0 | 0.1 | GO:0004719 | protein-L-isoaspartate (D-aspartate) O-methyltransferase activity(GO:0004719) |
0.0 | 0.1 | GO:0047760 | butyrate-CoA ligase activity(GO:0047760) |
0.0 | 2.2 | GO:0004222 | metalloendopeptidase activity(GO:0004222) |
0.0 | 0.1 | GO:0008113 | peptide-methionine (S)-S-oxide reductase activity(GO:0008113) |
0.0 | 0.1 | GO:0036042 | long-chain fatty acyl-CoA binding(GO:0036042) |
0.0 | 0.1 | GO:0030346 | protein phosphatase 2B binding(GO:0030346) |
0.0 | 3.6 | GO:0004252 | serine-type endopeptidase activity(GO:0004252) |
0.0 | 0.1 | GO:0045499 | chemorepellent activity(GO:0045499) |
0.0 | 0.0 | GO:0004791 | thioredoxin-disulfide reductase activity(GO:0004791) |
0.0 | 0.1 | GO:0004449 | isocitrate dehydrogenase (NAD+) activity(GO:0004449) |
0.0 | 0.4 | GO:0005540 | hyaluronic acid binding(GO:0005540) |
0.0 | 0.1 | GO:0015288 | porin activity(GO:0015288) |
0.0 | 0.1 | GO:0036402 | proteasome-activating ATPase activity(GO:0036402) |
0.0 | 0.1 | GO:0004982 | N-formyl peptide receptor activity(GO:0004982) |
0.0 | 0.4 | GO:0070003 | threonine-type endopeptidase activity(GO:0004298) threonine-type peptidase activity(GO:0070003) |
0.0 | 0.1 | GO:0051377 | mannose-ethanolamine phosphotransferase activity(GO:0051377) |
0.0 | 0.0 | GO:0008796 | bis(5'-nucleosyl)-tetraphosphatase activity(GO:0008796) |
0.0 | 0.2 | GO:0031210 | phosphatidylcholine binding(GO:0031210) |
0.0 | 0.1 | GO:0022835 | transmitter-gated ion channel activity(GO:0022824) transmitter-gated channel activity(GO:0022835) |
0.0 | 0.1 | GO:0004708 | MAP kinase kinase activity(GO:0004708) |
0.0 | 0.0 | GO:0004924 | oncostatin-M receptor activity(GO:0004924) |
0.0 | 0.2 | GO:0008353 | RNA polymerase II carboxy-terminal domain kinase activity(GO:0008353) |
0.0 | 0.1 | GO:0051434 | BH3 domain binding(GO:0051434) |
0.0 | 0.1 | GO:0016421 | CoA carboxylase activity(GO:0016421) |
0.0 | 0.1 | GO:0033691 | sialic acid binding(GO:0033691) |
0.0 | 0.2 | GO:0042800 | histone methyltransferase activity (H3-K4 specific)(GO:0042800) |
0.0 | 0.1 | GO:0005412 | glucose:sodium symporter activity(GO:0005412) |
0.0 | 0.0 | GO:0015065 | uridine nucleotide receptor activity(GO:0015065) G-protein coupled pyrimidinergic nucleotide receptor activity(GO:0071553) |
0.0 | 0.1 | GO:0070095 | fructose-6-phosphate binding(GO:0070095) |
0.0 | 0.2 | GO:0016854 | racemase and epimerase activity(GO:0016854) |
0.0 | 0.1 | GO:0001972 | retinoic acid binding(GO:0001972) |
0.0 | 0.0 | GO:0043237 | laminin-1 binding(GO:0043237) |
0.0 | 0.0 | GO:0016174 | NAD(P)H oxidase activity(GO:0016174) |
0.0 | 0.1 | GO:0050700 | CARD domain binding(GO:0050700) |
0.0 | 0.1 | GO:0005243 | gap junction channel activity(GO:0005243) |
0.0 | 0.0 | GO:0031628 | opioid receptor binding(GO:0031628) |
0.0 | 0.2 | GO:0004653 | polypeptide N-acetylgalactosaminyltransferase activity(GO:0004653) |
0.0 | 0.4 | GO:0019905 | syntaxin binding(GO:0019905) |
0.0 | 0.3 | GO:0001102 | RNA polymerase II activating transcription factor binding(GO:0001102) |
0.0 | 0.0 | GO:0015925 | galactosidase activity(GO:0015925) |
0.0 | 0.0 | GO:0004946 | bombesin receptor activity(GO:0004946) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.9 | 28.1 | PID NETRIN PATHWAY | Netrin-mediated signaling events |
0.4 | 6.4 | PID ERBB NETWORK PATHWAY | ErbB receptor signaling network |
0.4 | 0.8 | PID EPHA2 FWD PATHWAY | EPHA2 forward signaling |
0.4 | 7.0 | PID HEDGEHOG 2PATHWAY | Signaling events mediated by the Hedgehog family |
0.3 | 1.4 | PID NFAT 3PATHWAY | Role of Calcineurin-dependent NFAT signaling in lymphocytes |
0.3 | 4.1 | PID SYNDECAN 3 PATHWAY | Syndecan-3-mediated signaling events |
0.3 | 0.3 | PID IGF1 PATHWAY | IGF1 pathway |
0.3 | 3.6 | PID NFKAPPAB ATYPICAL PATHWAY | Atypical NF-kappaB pathway |
0.3 | 3.8 | PID TCR JNK PATHWAY | JNK signaling in the CD4+ TCR pathway |
0.2 | 7.0 | PID ERBB1 INTERNALIZATION PATHWAY | Internalization of ErbB1 |
0.2 | 3.1 | PID ERBB4 PATHWAY | ErbB4 signaling events |
0.2 | 0.2 | PID LPA4 PATHWAY | LPA4-mediated signaling events |
0.2 | 5.8 | PID LKB1 PATHWAY | LKB1 signaling events |
0.2 | 2.0 | SA B CELL RECEPTOR COMPLEXES | Antigen binding to B cell receptors activates protein tyrosine kinases, such as the Src family, which ultimate activate MAP kinases. |
0.1 | 4.5 | ST WNT BETA CATENIN PATHWAY | Wnt/beta-catenin Pathway |
0.1 | 9.2 | PID BETA CATENIN NUC PATHWAY | Regulation of nuclear beta catenin signaling and target gene transcription |
0.1 | 3.1 | ST MYOCYTE AD PATHWAY | Myocyte Adrenergic Pathway is a specific case of the generalized Adrenergic Pathway. |
0.1 | 0.3 | PID PI3K PLC TRK PATHWAY | Trk receptor signaling mediated by PI3K and PLC-gamma |
0.1 | 1.2 | PID S1P S1P2 PATHWAY | S1P2 pathway |
0.1 | 4.4 | NABA COLLAGENS | Genes encoding collagen proteins |
0.1 | 0.7 | PID INSULIN PATHWAY | Insulin Pathway |
0.1 | 2.0 | PID CONE PATHWAY | Visual signal transduction: Cones |
0.1 | 0.1 | PID FAS PATHWAY | FAS (CD95) signaling pathway |
0.1 | 1.3 | PID P38 ALPHA BETA PATHWAY | Regulation of p38-alpha and p38-beta |
0.1 | 0.2 | PID AVB3 OPN PATHWAY | Osteopontin-mediated events |
0.1 | 2.2 | PID INTEGRIN2 PATHWAY | Beta2 integrin cell surface interactions |
0.1 | 0.3 | PID S1P S1P3 PATHWAY | S1P3 pathway |
0.1 | 1.5 | PID CD40 PATHWAY | CD40/CD40L signaling |
0.1 | 0.2 | SA G1 AND S PHASES | Cdk2, 4, and 6 bind cyclin D in G1, while cdk2/cyclin E promotes the G1/S transition. |
0.1 | 0.8 | PID ARF6 DOWNSTREAM PATHWAY | Arf6 downstream pathway |
0.1 | 1.2 | PID PS1 PATHWAY | Presenilin action in Notch and Wnt signaling |
0.1 | 0.4 | PID NECTIN PATHWAY | Nectin adhesion pathway |
0.1 | 2.4 | PID SHP2 PATHWAY | SHP2 signaling |
0.1 | 1.4 | PID NCADHERIN PATHWAY | N-cadherin signaling events |
0.1 | 0.9 | PID GLYPICAN 1PATHWAY | Glypican 1 network |
0.1 | 8.7 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
0.1 | 0.4 | SA PTEN PATHWAY | PTEN is a tumor suppressor that dephosphorylates the lipid messenger phosphatidylinositol triphosphate. |
0.0 | 0.2 | PID SYNDECAN 1 PATHWAY | Syndecan-1-mediated signaling events |
0.0 | 0.5 | PID INSULIN GLUCOSE PATHWAY | Insulin-mediated glucose transport |
0.0 | 0.4 | PID ALK2 PATHWAY | ALK2 signaling events |
0.0 | 0.6 | PID ALPHA SYNUCLEIN PATHWAY | Alpha-synuclein signaling |
0.0 | 0.9 | PID EPHA FWDPATHWAY | EPHA forward signaling |
0.0 | 0.4 | PID FCER1 PATHWAY | Fc-epsilon receptor I signaling in mast cells |
0.0 | 0.0 | ST INTERFERON GAMMA PATHWAY | Interferon gamma pathway. |
0.0 | 0.2 | PID AMB2 NEUTROPHILS PATHWAY | amb2 Integrin signaling |
0.0 | 1.1 | PID TAP63 PATHWAY | Validated transcriptional targets of TAp63 isoforms |
0.0 | 0.0 | PID TRAIL PATHWAY | TRAIL signaling pathway |
0.0 | 0.1 | PID IL8 CXCR2 PATHWAY | IL8- and CXCR2-mediated signaling events |
0.0 | 0.6 | PID RAC1 REG PATHWAY | Regulation of RAC1 activity |
0.0 | 0.7 | PID ATR PATHWAY | ATR signaling pathway |
0.0 | 0.7 | PID TCR PATHWAY | TCR signaling in naïve CD4+ T cells |
0.0 | 0.2 | PID CXCR3 PATHWAY | CXCR3-mediated signaling events |
0.0 | 0.1 | PID IL12 STAT4 PATHWAY | IL12 signaling mediated by STAT4 |
0.0 | 0.3 | PID LIS1 PATHWAY | Lissencephaly gene (LIS1) in neuronal migration and development |
0.0 | 0.4 | PID HDAC CLASSII PATHWAY | Signaling events mediated by HDAC Class II |
0.0 | 0.1 | PID RHODOPSIN PATHWAY | Visual signal transduction: Rods |
0.0 | 0.0 | PID THROMBIN PAR4 PATHWAY | PAR4-mediated thrombin signaling events |
0.0 | 0.1 | PID TXA2PATHWAY | Thromboxane A2 receptor signaling |
0.0 | 0.0 | ST GA13 PATHWAY | G alpha 13 Pathway |
0.0 | 0.0 | PID ANGIOPOIETIN RECEPTOR PATHWAY | Angiopoietin receptor Tie2-mediated signaling |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.1 | 28.4 | REACTOME MYOGENESIS | Genes involved in Myogenesis |
0.9 | 10.4 | REACTOME DCC MEDIATED ATTRACTIVE SIGNALING | Genes involved in DCC mediated attractive signaling |
0.8 | 0.8 | REACTOME CELL CELL COMMUNICATION | Genes involved in Cell-Cell communication |
0.8 | 9.9 | REACTOME CRMPS IN SEMA3A SIGNALING | Genes involved in CRMPs in Sema3A signaling |
0.6 | 0.6 | REACTOME IL 2 SIGNALING | Genes involved in Interleukin-2 signaling |
0.6 | 0.6 | REACTOME CELL CYCLE CHECKPOINTS | Genes involved in Cell Cycle Checkpoints |
0.5 | 0.5 | REACTOME REGULATION OF INSULIN SECRETION BY ACETYLCHOLINE | Genes involved in Regulation of Insulin Secretion by Acetylcholine |
0.5 | 3.7 | REACTOME CREATION OF C4 AND C2 ACTIVATORS | Genes involved in Creation of C4 and C2 activators |
0.5 | 1.9 | REACTOME TRANSMISSION ACROSS CHEMICAL SYNAPSES | Genes involved in Transmission across Chemical Synapses |
0.4 | 0.4 | REACTOME IL 3 5 AND GM CSF SIGNALING | Genes involved in Interleukin-3, 5 and GM-CSF signaling |
0.4 | 9.0 | REACTOME INTERACTION BETWEEN L1 AND ANKYRINS | Genes involved in Interaction between L1 and Ankyrins |
0.4 | 7.8 | REACTOME CGMP EFFECTS | Genes involved in cGMP effects |
0.4 | 3.9 | REACTOME INHIBITION OF VOLTAGE GATED CA2 CHANNELS VIA GBETA GAMMA SUBUNITS | Genes involved in Inhibition of voltage gated Ca2+ channels via Gbeta/gamma subunits |
0.4 | 8.5 | REACTOME NETRIN1 SIGNALING | Genes involved in Netrin-1 signaling |
0.4 | 4.0 | REACTOME DOWNREGULATION OF ERBB2 ERBB3 SIGNALING | Genes involved in Downregulation of ERBB2:ERBB3 signaling |
0.3 | 1.7 | REACTOME INITIAL TRIGGERING OF COMPLEMENT | Genes involved in Initial triggering of complement |
0.3 | 6.1 | REACTOME ADHERENS JUNCTIONS INTERACTIONS | Genes involved in Adherens junctions interactions |
0.3 | 6.8 | REACTOME EGFR DOWNREGULATION | Genes involved in EGFR downregulation |
0.3 | 0.3 | REACTOME CREB PHOSPHORYLATION THROUGH THE ACTIVATION OF CAMKII | Genes involved in CREB phosphorylation through the activation of CaMKII |
0.3 | 2.4 | REACTOME TRANSPORT OF ORGANIC ANIONS | Genes involved in Transport of organic anions |
0.3 | 4.4 | REACTOME NA CL DEPENDENT NEUROTRANSMITTER TRANSPORTERS | Genes involved in Na+/Cl- dependent neurotransmitter transporters |
0.3 | 11.0 | REACTOME NRAGE SIGNALS DEATH THROUGH JNK | Genes involved in NRAGE signals death through JNK |
0.3 | 13.9 | REACTOME COLLAGEN FORMATION | Genes involved in Collagen formation |
0.3 | 3.1 | REACTOME PURINE SALVAGE | Genes involved in Purine salvage |
0.2 | 3.3 | REACTOME NEPHRIN INTERACTIONS | Genes involved in Nephrin interactions |
0.2 | 4.9 | REACTOME NCAM1 INTERACTIONS | Genes involved in NCAM1 interactions |
0.2 | 2.4 | REACTOME IONOTROPIC ACTIVITY OF KAINATE RECEPTORS | Genes involved in Ionotropic activity of Kainate Receptors |
0.2 | 4.1 | REACTOME RNA POL III TRANSCRIPTION TERMINATION | Genes involved in RNA Polymerase III Transcription Termination |
0.2 | 1.3 | REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 2 PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 2 Promoter |
0.2 | 3.9 | REACTOME INSULIN SYNTHESIS AND PROCESSING | Genes involved in Insulin Synthesis and Processing |
0.2 | 1.1 | REACTOME NFKB IS ACTIVATED AND SIGNALS SURVIVAL | Genes involved in NF-kB is activated and signals survival |
0.2 | 3.1 | REACTOME GPVI MEDIATED ACTIVATION CASCADE | Genes involved in GPVI-mediated activation cascade |
0.2 | 2.8 | REACTOME REGULATION OF GENE EXPRESSION IN BETA CELLS | Genes involved in Regulation of gene expression in beta cells |
0.2 | 2.4 | REACTOME CLASS C 3 METABOTROPIC GLUTAMATE PHEROMONE RECEPTORS | Genes involved in Class C/3 (Metabotropic glutamate/pheromone receptors) |
0.2 | 1.3 | REACTOME P38MAPK EVENTS | Genes involved in p38MAPK events |
0.2 | 1.8 | REACTOME GABA SYNTHESIS RELEASE REUPTAKE AND DEGRADATION | Genes involved in GABA synthesis, release, reuptake and degradation |
0.2 | 2.1 | REACTOME JNK C JUN KINASES PHOSPHORYLATION AND ACTIVATION MEDIATED BY ACTIVATED HUMAN TAK1 | Genes involved in JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1 |
0.2 | 1.3 | REACTOME TIE2 SIGNALING | Genes involved in Tie2 Signaling |
0.2 | 0.5 | REACTOME PLATELET HOMEOSTASIS | Genes involved in Platelet homeostasis |
0.2 | 1.5 | REACTOME OTHER SEMAPHORIN INTERACTIONS | Genes involved in Other semaphorin interactions |
0.1 | 1.1 | REACTOME INTEGRATION OF PROVIRUS | Genes involved in Integration of provirus |
0.1 | 0.5 | REACTOME DSCAM INTERACTIONS | Genes involved in DSCAM interactions |
0.1 | 1.7 | REACTOME POL SWITCHING | Genes involved in Polymerase switching |
0.1 | 4.0 | REACTOME TRANSPORT TO THE GOLGI AND SUBSEQUENT MODIFICATION | Genes involved in Transport to the Golgi and subsequent modification |
0.1 | 4.2 | REACTOME ION TRANSPORT BY P TYPE ATPASES | Genes involved in Ion transport by P-type ATPases |
0.1 | 5.1 | REACTOME VOLTAGE GATED POTASSIUM CHANNELS | Genes involved in Voltage gated Potassium channels |
0.1 | 1.3 | REACTOME SEROTONIN RECEPTORS | Genes involved in Serotonin receptors |
0.1 | 0.7 | REACTOME INWARDLY RECTIFYING K CHANNELS | Genes involved in Inwardly rectifying K+ channels |
0.1 | 0.4 | REACTOME GLUTAMATE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Glutamate Neurotransmitter Release Cycle |
0.1 | 1.0 | REACTOME SIGNAL ATTENUATION | Genes involved in Signal attenuation |
0.1 | 1.6 | REACTOME UNBLOCKING OF NMDA RECEPTOR GLUTAMATE BINDING AND ACTIVATION | Genes involved in Unblocking of NMDA receptor, glutamate binding and activation |
0.1 | 2.5 | REACTOME YAP1 AND WWTR1 TAZ STIMULATED GENE EXPRESSION | Genes involved in YAP1- and WWTR1 (TAZ)-stimulated gene expression |
0.1 | 0.3 | REACTOME ADP SIGNALLING THROUGH P2RY12 | Genes involved in ADP signalling through P2Y purinoceptor 12 |
0.1 | 1.1 | REACTOME GABA A RECEPTOR ACTIVATION | Genes involved in GABA A receptor activation |
0.1 | 1.3 | REACTOME ACYL CHAIN REMODELLING OF PI | Genes involved in Acyl chain remodelling of PI |
0.1 | 0.1 | REACTOME SCFSKP2 MEDIATED DEGRADATION OF P27 P21 | Genes involved in SCF(Skp2)-mediated degradation of p27/p21 |
0.1 | 0.9 | REACTOME GRB2 SOS PROVIDES LINKAGE TO MAPK SIGNALING FOR INTERGRINS | Genes involved in GRB2:SOS provides linkage to MAPK signaling for Intergrins |
0.1 | 1.6 | REACTOME PI3K EVENTS IN ERBB4 SIGNALING | Genes involved in PI3K events in ERBB4 signaling |
0.1 | 0.1 | REACTOME ACTIVATION OF THE PRE REPLICATIVE COMPLEX | Genes involved in Activation of the pre-replicative complex |
0.1 | 0.1 | REACTOME TGF BETA RECEPTOR SIGNALING IN EMT EPITHELIAL TO MESENCHYMAL TRANSITION | Genes involved in TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) |
0.1 | 0.3 | REACTOME NEGATIVE REGULATION OF THE PI3K AKT NETWORK | Genes involved in Negative regulation of the PI3K/AKT network |
0.1 | 1.1 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GLP1 | Genes involved in Synthesis, Secretion, and Inactivation of Glucagon-like Peptide-1 (GLP-1) |
0.1 | 1.9 | REACTOME POST TRANSLATIONAL MODIFICATION SYNTHESIS OF GPI ANCHORED PROTEINS | Genes involved in Post-translational modification: synthesis of GPI-anchored proteins |
0.1 | 0.6 | REACTOME PHOSPHORYLATION OF CD3 AND TCR ZETA CHAINS | Genes involved in Phosphorylation of CD3 and TCR zeta chains |
0.1 | 1.3 | REACTOME FORMATION OF INCISION COMPLEX IN GG NER | Genes involved in Formation of incision complex in GG-NER |
0.1 | 0.7 | REACTOME PURINE RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHESIS | Genes involved in Purine ribonucleoside monophosphate biosynthesis |
0.1 | 0.3 | REACTOME SIGNAL TRANSDUCTION BY L1 | Genes involved in Signal transduction by L1 |
0.1 | 0.2 | REACTOME NFKB ACTIVATION THROUGH FADD RIP1 PATHWAY MEDIATED BY CASPASE 8 AND10 | Genes involved in NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10 |
0.1 | 0.4 | REACTOME CIRCADIAN REPRESSION OF EXPRESSION BY REV ERBA | Genes involved in Circadian Repression of Expression by REV-ERBA |
0.1 | 0.1 | REACTOME BINDING AND ENTRY OF HIV VIRION | Genes involved in Binding and entry of HIV virion |
0.1 | 2.4 | REACTOME AMINO ACID AND OLIGOPEPTIDE SLC TRANSPORTERS | Genes involved in Amino acid and oligopeptide SLC transporters |
0.1 | 0.7 | REACTOME NOD1 2 SIGNALING PATHWAY | Genes involved in NOD1/2 Signaling Pathway |
0.1 | 0.1 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS | Genes involved in Synthesis of bile acids and bile salts |
0.1 | 0.3 | REACTOME PACKAGING OF TELOMERE ENDS | Genes involved in Packaging Of Telomere Ends |
0.1 | 1.3 | REACTOME EXTRACELLULAR MATRIX ORGANIZATION | Genes involved in Extracellular matrix organization |
0.0 | 0.2 | REACTOME ACTIVATION OF RAC | Genes involved in Activation of Rac |
0.0 | 0.8 | REACTOME IL RECEPTOR SHC SIGNALING | Genes involved in Interleukin receptor SHC signaling |
0.0 | 0.4 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS VIA 24 HYDROXYCHOLESTEROL | Genes involved in Synthesis of bile acids and bile salts via 24-hydroxycholesterol |
0.0 | 0.5 | REACTOME MITOCHONDRIAL FATTY ACID BETA OXIDATION | Genes involved in Mitochondrial Fatty Acid Beta-Oxidation |
0.0 | 0.2 | REACTOME REGULATION OF THE FANCONI ANEMIA PATHWAY | Genes involved in Regulation of the Fanconi anemia pathway |
0.0 | 0.1 | REACTOME XENOBIOTICS | Genes involved in Xenobiotics |
0.0 | 0.6 | REACTOME GAP JUNCTION ASSEMBLY | Genes involved in Gap junction assembly |
0.0 | 0.4 | REACTOME COMPLEMENT CASCADE | Genes involved in Complement cascade |
0.0 | 0.6 | REACTOME BRANCHED CHAIN AMINO ACID CATABOLISM | Genes involved in Branched-chain amino acid catabolism |
0.0 | 0.3 | REACTOME POTASSIUM CHANNELS | Genes involved in Potassium Channels |
0.0 | 0.1 | REACTOME RIP MEDIATED NFKB ACTIVATION VIA DAI | Genes involved in RIP-mediated NFkB activation via DAI |
0.0 | 0.0 | REACTOME APC C CDC20 MEDIATED DEGRADATION OF MITOTIC PROTEINS | Genes involved in APC/C:Cdc20 mediated degradation of mitotic proteins |
0.0 | 0.3 | REACTOME SYNTHESIS OF SUBSTRATES IN N GLYCAN BIOSYTHESIS | Genes involved in Synthesis of substrates in N-glycan biosythesis |
0.0 | 0.2 | REACTOME GENERATION OF SECOND MESSENGER MOLECULES | Genes involved in Generation of second messenger molecules |
0.0 | 0.2 | REACTOME ENDOGENOUS STEROLS | Genes involved in Endogenous sterols |
0.0 | 1.1 | REACTOME AUTODEGRADATION OF THE E3 UBIQUITIN LIGASE COP1 | Genes involved in Autodegradation of the E3 ubiquitin ligase COP1 |
0.0 | 0.1 | REACTOME IRAK1 RECRUITS IKK COMPLEX | Genes involved in IRAK1 recruits IKK complex |
0.0 | 4.0 | REACTOME PEPTIDE LIGAND BINDING RECEPTORS | Genes involved in Peptide ligand-binding receptors |
0.0 | 0.2 | REACTOME CYTOCHROME P450 ARRANGED BY SUBSTRATE TYPE | Genes involved in Cytochrome P450 - arranged by substrate type |
0.0 | 0.0 | REACTOME TRANSFERRIN ENDOCYTOSIS AND RECYCLING | Genes involved in Transferrin endocytosis and recycling |
0.0 | 0.1 | REACTOME PD1 SIGNALING | Genes involved in PD-1 signaling |
0.0 | 0.0 | REACTOME DOPAMINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Dopamine Neurotransmitter Release Cycle |
0.0 | 0.0 | REACTOME P53 INDEPENDENT G1 S DNA DAMAGE CHECKPOINT | Genes involved in p53-Independent G1/S DNA damage checkpoint |
0.0 | 0.0 | REACTOME DOWNSTREAM TCR SIGNALING | Genes involved in Downstream TCR signaling |
0.0 | 0.0 | REACTOME NEURONAL SYSTEM | Genes involved in Neuronal System |
0.0 | 0.1 | REACTOME CS DS DEGRADATION | Genes involved in CS/DS degradation |